| Year |
Citation |
Score |
| 2020 |
Ózsvári B, Magalhães LG, Latimer J, Kangasmetsa J, Sotgia F, Lisanti MP. A Myristoyl Amide Derivative of Doxycycline Potently Targets Cancer Stem Cells (CSCs) and Prevents Spontaneous Metastasis, Without Retaining Antibiotic Activity. Frontiers in Oncology. 10: 1528. PMID 33042796 DOI: 10.3389/Fonc.2020.01528 |
0.359 |
|
| 2020 |
Chen K, Jiao X, Ashton A, Di Rocco A, Pestell TG, Sun Y, Zhao J, Casimiro MC, Li Z, Lisanti MP, McCue PA, Shen D, Achilefu S, Rui H, Pestell RG. The membrane-associated form of cyclin D1 enhances cellular invasion. Oncogenesis. 9: 83. PMID 32948740 DOI: 10.1038/s41389-020-00266-y |
0.435 |
|
| 2020 |
Brindisi M, Fiorillo M, Frattaruolo L, Sotgia F, Lisanti MP, Cappello AR. Cholesterol and Mevalonate: Two Metabolites Involved in Breast Cancer Progression and Drug Resistance through the ERRα Pathway. Cells. 9. PMID 32751976 DOI: 10.3390/Cells9081819 |
0.374 |
|
| 2020 |
Fiorillo M, Tóth F, Brindisi M, Sotgia F, Lisanti MP. Deferiprone (DFP) Targets Cancer Stem Cell (CSC) Propagation by Inhibiting Mitochondrial Metabolism and Inducing ROS Production. Cells. 9. PMID 32585919 DOI: 10.3390/Cells9061529 |
0.33 |
|
| 2019 |
Volpari T, De Santis F, Bracken AP, Pupa SM, Buschbeck M, Wegner A, Di Cosimo S, Lisanti MP, Dotti G, Massaia M, Pruneri G, Anichini A, Fortunato O, De Braud F, Del Vecchio M, et al. Anticancer innovative therapy: Highlights from the ninth annual meeting. Cytokine & Growth Factor Reviews. 51: 1-9. PMID 31862236 DOI: 10.1016/J.Cytogfr.2019.12.002 |
0.327 |
|
| 2019 |
Sivalingam VN, Latif A, Kitson S, McVey R, Finegan KG, Marshall K, Lisanti MP, Sotgia F, Stratford IJ, Crosbie EJ. Hypoxia and hyperglycaemia determine why some endometrial tumours fail to respond to metformin. British Journal of Cancer. PMID 31819173 DOI: 10.1038/S41416-019-0627-Y |
0.326 |
|
| 2019 |
Pellegrino M, Rizza P, Donà A, Nigro A, Ricci E, Fiorillo M, Perrotta I, Lanzino M, Giordano C, Bonofiglio D, Bruno R, Sotgia F, Lisanti MP, Sisci D, Morelli C. FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer. Cancers. 11. PMID 31769419 DOI: 10.3390/Cancers11121858 |
0.362 |
|
| 2019 |
Frattaruolo L, Fiorillo M, Brindisi M, Curcio R, Dolce V, Lacret R, Truman AW, Sotgia F, Lisanti MP, Cappello AR. Thioalbamide, A Thioamidated Peptide from , Affects Tumor Growth and Stemness by Inducing Metabolic Dysfunction and Oxidative Stress. Cells. 8. PMID 31717378 DOI: 10.3390/Cells8111408 |
0.347 |
|
| 2019 |
De Francesco EM, Ózsvári B, Sotgia F, Lisanti MP. Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine). Frontiers in Oncology. 9: 615. PMID 31440463 DOI: 10.3389/Fonc.2019.00615 |
0.363 |
|
| 2018 |
Fiorillo M, Sotgia F, Lisanti MP. "Energetic" Cancer Stem Cells (e-CSCs): A New Hyper-Metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial Energy. Frontiers in Oncology. 8: 677. PMID 30805301 DOI: 10.3389/Fonc.2018.00677 |
0.353 |
|
| 2018 |
Scatena C, Roncella M, Di Paolo A, Aretini P, Menicagli M, Fanelli G, Marini C, Mazzanti CM, Ghilli M, Sotgia F, Lisanti MP, Naccarato AG. Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study. Frontiers in Oncology. 8: 452. PMID 30364293 DOI: 10.3389/Fonc.2018.00452 |
0.33 |
|
| 2018 |
Sotgia F, Ozsvari B, Fiorillo M, De Francesco EM, Bonuccelli G, Lisanti MP. A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX. Cell Cycle (Georgetown, Tex.). 1-10. PMID 30257595 DOI: 10.1080/15384101.2018.1515551 |
0.31 |
|
| 2018 |
De Francesco EM, Sotgia F, Lisanti MP. Cancer stem cells (CSCs): metabolic strategies for their identification and eradication. The Biochemical Journal. 475: 1611-1634. PMID 29743249 DOI: 10.1042/Bcj20170164 |
0.337 |
|
| 2018 |
Fiorillo M, Peiris-Pagès M, Sanchez-Alvarez R, Bartella L, Di Donna L, Dolce V, Sindona G, Sotgia F, Cappello AR, Lisanti MP. Bergamot natural products eradicate cancer stem cells (CSCs) by targeting mevalonate, Rho-GDI-signalling and mitochondrial metabolism. Biochimica Et Biophysica Acta. PMID 29626418 DOI: 10.1016/J.Bbabio.2018.03.018 |
0.348 |
|
| 2018 |
Peiris-Pagès M, Bonuccelli G, Sotgia F, Lisanti MP. Mitochondrial fission as a driver of stemness in tumor cells: mDIVI1 inhibits mitochondrial function, cell migration and cancer stem cell (CSC) signalling. Oncotarget. 9: 13254-13275. PMID 29568355 DOI: 10.18632/Oncotarget.24285 |
0.341 |
|
| 2017 |
Monti D, Sotgia F, Whitaker-Menezes D, Tuluc M, Birbe R, Berger A, Lazar M, Cotzia P, Draganova-Tacheva R, Lin Z, Domingo-Vidal M, Newberg A, Lisanti MP, Martinez-Outschoorn U. Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer. Seminars in Oncology. 44: 226-232. PMID 29248134 DOI: 10.1053/J.Seminoncol.2017.10.001 |
0.353 |
|
| 2017 |
Mikkilineni L, Whitaker-Menezes D, Domingo-Vidal M, Sprandio J, Avena P, Cotzia P, Dulau-Florea A, Gong J, Uppal G, Zhan T, Leiby B, Lin Z, Pro B, Sotgia F, Lisanti MP, et al. Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment. Seminars in Oncology. 44: 218-225. PMID 29248133 DOI: 10.1053/J.Seminoncol.2017.10.003 |
0.362 |
|
| 2017 |
De Francesco EM, Sotgia F, Clarke RB, Lisanti MP, Maggiolini M. G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts. International Journal of Molecular Sciences. 18. PMID 29240722 DOI: 10.3390/Ijms18122713 |
0.338 |
|
| 2017 |
De Francesco EM, Sims AH, Maggiolini M, Sotgia F, Lisanti MP, Clarke RB. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment. Breast Cancer Research : Bcr. 19: 129. PMID 29212519 DOI: 10.1186/S13058-017-0923-5 |
0.365 |
|
| 2017 |
Pestell TG, Jiao X, Kumar M, Peck AR, Prisco M, Deng S, Li Z, Ertel A, Casimiro MC, Ju X, Di Rocco A, Di Sante G, Katiyar S, Shupp A, Lisanti MP, et al. Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth. Oncotarget. 8: 81754-81775. PMID 29137220 DOI: 10.18632/Oncotarget.19953 |
0.539 |
|
| 2017 |
Ozsvari B, Sotgia F, Simmons K, Trowbridge R, Foster R, Lisanti MP. Mitoketoscins: Novel mitochondrial inhibitors for targeting ketone metabolism in cancer stem cells (CSCs). Oncotarget. 8: 78340-78350. PMID 29108233 DOI: 10.18632/Oncotarget.21259 |
0.347 |
|
| 2017 |
Sotgia F, Fiorillo M, Lisanti MP. Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics. Oncotarget. 8: 68730-68745. PMID 28978152 DOI: 10.18632/Oncotarget.19612 |
0.309 |
|
| 2017 |
Sotgia F, Lisanti MP. Mitochondrial markers predict survival and progression in non-small cell lung cancer (NSCLC) patients: Use as companion diagnostics. Oncotarget. 8: 68095-68107. PMID 28978099 DOI: 10.18632/Oncotarget.19677 |
0.303 |
|
| 2017 |
De Francesco EM, Bonuccelli G, Maggiolini M, Sotgia F, Lisanti MP. Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs). Oncotarget. 8: 67269-67286. PMID 28978032 DOI: 10.18632/Oncotarget.18428 |
0.32 |
|
| 2017 |
Sotgia F, Lisanti MP. Mitochondrial biomarkers predict tumor progression and poor overall survival in gastric cancers: Companion diagnostics for personalized medicine. Oncotarget. 8: 67117-67128. PMID 28978020 DOI: 10.18632/Oncotarget.19962 |
0.306 |
|
| 2017 |
Sotgia F, Lisanti MP. Mitochondrial mRNA transcripts predict overall survival, tumor recurrence and progression in serous ovarian cancer: Companion diagnostics for cancer therapy. Oncotarget. 8: 66925-66939. PMID 28978006 DOI: 10.18632/Oncotarget.19963 |
0.303 |
|
| 2017 |
Fiorillo M, Sotgia F, Sisci D, Cappello AR, Lisanti MP. Mitochondrial "power" drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer. Oncotarget. 8: 20309-20327. PMID 28411284 DOI: 10.18632/Oncotarget.15852 |
0.34 |
|
| 2017 |
Bonuccelli G, De Francesco EM, de Boer R, Tanowitz HB, Lisanti MP. NADH autofluorescence, a new metabolic biomarker for cancer stem cells: Identification of Vitamin C and CAPE as natural products targeting "stemness". Oncotarget. PMID 28223550 DOI: 10.18632/Oncotarget.15400 |
0.321 |
|
| 2017 |
Martinez-Outschoorn UE, Peiris-Pagés M, Pestell RG, Sotgia F, Lisanti MP. Cancer metabolism: a therapeutic perspective. Nature Reviews. Clinical Oncology. PMID 28094266 DOI: 10.1038/Nrclinonc.2017.1 |
0.442 |
|
| 2016 |
Bonuccelli G, Peiris-Pages M, Ozsvari B, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity. Oncotarget. PMID 28039467 DOI: 10.18632/Oncotarget.14196 |
0.386 |
|
| 2016 |
Ju X, Jiao X, Ertel A, Casimiro MC, Di Sante G, Deng S, Li Z, Di Rocco A, Zhan T, Hawkins A, Stoyanova T, Ando S, Fatatis A, Lisanti MP, Gomella LG, et al. SRC ONCOGENE INDUCES TROP2 PROTEOLYTIC ACTIVATION VIA CYCLIN D1. Cancer Research. PMID 27634768 DOI: 10.1158/0008-5472.Can-15-3327 |
0.506 |
|
| 2016 |
Peiris-Pagès M, Martinez-Outschoorn UE, Pestell RG, Sotgia F, Lisanti MP. Cancer stem cell metabolism. Breast Cancer Research : Bcr. 18: 55. PMID 27220421 DOI: 10.1186/S13058-016-0712-6 |
0.493 |
|
| 2016 |
Martinez-Outschoorn UE, Peiris-Pagés M, Pestell RG, Sotgia F, Lisanti MP. Cancer metabolism: a therapeutic perspective. Nature Reviews. Clinical Oncology. PMID 27141887 DOI: 10.1038/Nrclinonc.2016.60 |
0.495 |
|
| 2016 |
Fiorillo M, Lamb R, Tanowitz HB, Mutti L, Krstic-Demonacos M, Cappello AR, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells. Oncotarget. PMID 27136895 DOI: 10.18632/Oncotarget.9122 |
0.332 |
|
| 2016 |
Johnson SM, Dempsey C, Chadwick A, Harrison S, Liu J, Di Y, McGinn OJ, Fiorillo M, Sotgia F, Lisanti M, Parihar M, Krishnan S, Saha V. Metabolic reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute lymphoblastic leukemia. Blood. PMID 27099150 DOI: 10.1182/Blood-2015-12-688051 |
0.351 |
|
| 2016 |
Klionsky DJ, Abdelmohsen K, Abe A, Abedin J, Abeliovich H, Arozena AA, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Lisanti MP, et al. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 Autophagy. 12: 443-443. PMID 26902590 DOI: 10.1080/15548627.2016.1147886 |
0.546 |
|
| 2016 |
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Lisanti MP, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356 |
0.681 |
|
| 2016 |
Al-Zoubi MS, Mazzanti CM, Zavaglia K, Hamad MA, Armogida I, Lisanti MP, Bevilacqua G. Homozygous T172T and Heterozygous G135C Variants of Homologous Recombination Repairing Protein RAD51 are Related to Sporadic Breast Cancer Susceptibility. Biochemical Genetics. 54: 83-94. PMID 26650628 DOI: 10.1007/S10528-015-9703-Z |
0.333 |
|
| 2016 |
Lisanti M. Abstract ES2-3: Metabolic asymmetry in breast cancer: Implications for personlised medicine Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-Es2-3 |
0.349 |
|
| 2016 |
Lisanti M. Abstract BS3-2: Targeting mitochrondria with FDA-approved antibiotics may be a new therapeutic strategy to eliminate cancer stem cells Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-Bs3-2 |
0.344 |
|
| 2015 |
Gutierrez-Pajares JL, Iturrieta J, Dulam V, Wang Y, Pavlides S, Malacari G, Lisanti MP, Frank PG. Caveolin-3 Promotes a Vascular Smooth Muscle Contractile Phenotype. Frontiers in Cardiovascular Medicine. 2: 27. PMID 26664898 DOI: 10.3389/Fcvm.2015.00027 |
0.676 |
|
| 2015 |
Casimiro MC, Di Sante G, Ju X, Li Z, Chen K, Crosariol M, Yaman I, Gormley M, Meng H, Lisanti MP, Pestell RG. Cyclin D1 promotes androgen-dependent DNA damage repair in prostate cancer cells. Cancer Research. PMID 26582866 DOI: 10.1158/0008-5472.Can-15-0999 |
0.484 |
|
| 2015 |
Lamb R, Bonuccelli G, Ozsvári B, Peiris-Pagès M, Fiorillo M, Smith DL, Bevilacqua G, Mazzanti CM, McDonnell LA, Naccarato AG, Chiu M, Wynne L, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling. Oncotarget. 6: 30453-71. PMID 26421711 DOI: 10.18632/Oncotarget.5852 |
0.404 |
|
| 2015 |
Farnie G, Sotgia F, Lisanti MP. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant. Oncotarget. 6: 30472-86. PMID 26421710 DOI: 10.18632/Oncotarget.5401 |
0.353 |
|
| 2015 |
Lamb R, Ozsvari B, Bonuccelli G, Smith DL, Pestell RG, Martinez-Outschoorn UE, Clarke RB, Sotgia F, Lisanti MP. Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells. Oncotarget. 6: 21892-905. PMID 26323205 DOI: 10.18632/Oncotarget.5260 |
0.558 |
|
| 2015 |
Casaburi I, Avena P, De Luca A, Chimento A, Sirianni R, Malivindi R, Rago V, Fiorillo M, Domanico F, Campana C, Cappello AR, Sotgia F, Lisanti MP, Pezzi V. Estrogen related receptor α (ERRα) a promising target for the therapy of adrenocortical carcinoma (ACC). Oncotarget. 6: 25135-48. PMID 26312764 DOI: 10.18632/Oncotarget.4722 |
0.377 |
|
| 2015 |
De Luca A, Fiorillo M, Peiris-Pagès M, Ozsvari B, Smith DL, Sanchez-Alvarez R, Martinez-Outschoorn UE, Cappello AR, Pezzi V, Lisanti MP, Sotgia F. Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells. Oncotarget. PMID 26087310 DOI: 10.18632/Oncotarget.4401 |
0.336 |
|
| 2015 |
Lamb R, Fiorillo M, Chadwick A, Ozsvari B, Reeves KJ, Smith DL, Clarke RB, Howell SJ, Cappello AR, Martinez-Outschoorn UE, Peiris-Pagès M, Sotgia F, Lisanti MP. Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy. Oncotarget. 6: 14005-25. PMID 26087309 DOI: 10.18632/Oncotarget.4159 |
0.329 |
|
| 2015 |
Ward R, Sims AH, Lee A, Lo C, Wynne L, Yusuf H, Gregson H, Lisanti MP, Sotgia F, Landberg G, Lamb R. Monocytes and macrophages, implications for breast cancer migration and stem cell-like activity and treatment. Oncotarget. 6: 14687-99. PMID 26008983 DOI: 10.18632/Oncotarget.4189 |
0.353 |
|
| 2015 |
Casimiro MC, Di Sante G, Crosariol M, Loro E, Dampier W, Ertel A, Yu Z, Saria EA, Papanikolaou A, Li Z, Wang C, Addya S, Lisanti MP, Fortina P, Cardiff RD, et al. Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis. Oncotarget. 6: 8525-38. PMID 25940700 DOI: 10.18632/Oncotarget.3267 |
0.485 |
|
| 2015 |
Peiris-Pagès M, Sotgia F, Lisanti MP. Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine Hedgehog-GLI signalling in breast cancer cells. Oncotarget. 6: 10728-45. PMID 25915429 DOI: 10.18632/Oncotarget.3828 |
0.389 |
|
| 2015 |
Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Caveolae and signalling in cancer. Nature Reviews. Cancer. 15: 225-37. PMID 25801618 DOI: 10.1038/Nrc3915 |
0.353 |
|
| 2015 |
Chen K, Wu K, Jiao X, Wang L, Ju X, Wang M, Di Sante G, Xu S, Wang Q, Li K, Sun X, Xu C, Li Z, Casimiro MC, Ertel A, ... ... Lisanti MP, et al. The Endogenous Cell-Fate Factor Dachshund Restrains Prostate Epithelial Cell Migration via Repression of Cytokine Secretion via a CXCL Signaling Module. Cancer Research. 75: 1992-2004. PMID 25769723 DOI: 10.1158/0008-5472.Can-14-0611 |
0.486 |
|
| 2015 |
Fiorillo M, Verre AF, Iliut M, Peiris-Pagés M, Ozsvari B, Gandara R, Cappello AR, Sotgia F, Vijayaraghavan A, Lisanti MP. Graphene oxide selectively targets cancer stem cells, across multiple tumor types: implications for non-toxic cancer treatment, via "differentiation-based nano-therapy". Oncotarget. 6: 3553-62. PMID 25708684 DOI: 10.18632/Oncotarget.3348 |
0.34 |
|
| 2015 |
Lamb R, Harrison H, Smith DL, Townsend PA, Jackson T, Ozsvari B, Martinez-Outschoorn UE, Pestell RG, Howell A, Lisanti MP, Sotgia F. Targeting tumor-initiating cells: eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction. Oncotarget. 6: 4585-601. PMID 25671304 DOI: 10.18632/Oncotarget.3278 |
0.559 |
|
| 2015 |
Lamb R, Ozsvari B, Lisanti CL, Tanowitz HB, Howell A, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease. Oncotarget. 6: 4569-84. PMID 25625193 DOI: 10.18632/Oncotarget.3174 |
0.355 |
|
| 2015 |
Di Sante G, Pestell TG, Casimiro MC, Bisetto S, Powell MJ, Lisanti MP, Cordon-Cardo C, Castillo-Martin M, Bonal DM, Debattisti V, Chen K, Wang L, He X, McBurney MW, Pestell RG. Loss of Sirt1 promotes prostatic intraepithelial neoplasia, reduces mitophagy, and delays PARK2 translocation to mitochondria. The American Journal of Pathology. 185: 266-79. PMID 25529796 DOI: 10.1016/J.Ajpath.2014.09.014 |
0.5 |
|
| 2014 |
Sotgia F, Martinez-Outschoorn UE, Lisanti MP. The reverse Warburg effect in osteosarcoma. Oncotarget. 5: 7982-3. PMID 25478627 DOI: 10.18632/Oncotarget.2352 |
0.4 |
|
| 2014 |
Sicoli D, Jiao X, Ju X, Velasco-Velazquez M, Ertel A, Addya S, Li Z, Andò S, Fatatis A, Paudyal B, Cristofanilli M, Thakur ML, Lisanti MP, Pestell RG. CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines. Cancer Research. 74: 7103-14. PMID 25452256 DOI: 10.1158/0008-5472.Can-14-0612 |
0.502 |
|
| 2014 |
Lamb R, Harrison H, Hulit J, Smith DL, Lisanti MP, Sotgia F. Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition. Oncotarget. 5: 11029-37. PMID 25415228 DOI: 10.18632/Oncotarget.2789 |
0.364 |
|
| 2014 |
Pavlides S, Gutierrez-Pajares JL, Katiyar S, Jasmin JF, Mercier I, Walters R, Pavlides C, Pestell RG, Lisanti MP, Frank PG. Caveolin-1 regulates the anti-atherogenic properties of macrophages. Cell and Tissue Research. 358: 821-31. PMID 25322709 DOI: 10.1007/S00441-014-2008-4 |
0.707 |
|
| 2014 |
Lamb R, Lisanti MP, Clarke RB, Landberg G. Co-ordination of cell cycle, migration and stem cell-like activity in breast cancer. Oncotarget. 5: 7833-42. PMID 25277201 DOI: 10.18632/Oncotarget.2312 |
0.35 |
|
| 2014 |
Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Metabolic asymmetry in cancer: a "balancing act" that promotes tumor growth. Cancer Cell. 26: 5-7. PMID 25026205 DOI: 10.1016/J.Ccr.2014.06.021 |
0.36 |
|
| 2014 |
Wright PK, Jones SB, Ardern N, Ward R, Clarke RB, Sotgia F, Lisanti MP, Landberg G, Lamb R. 17β-estradiol regulates giant vesicle formation via estrogen receptor-alpha in human breast cancer cells. Oncotarget. 5: 3055-65. PMID 24931391 DOI: 10.18632/Oncotarget.1824 |
0.364 |
|
| 2014 |
Li Z, Chen K, Jiao X, Wang C, Willmarth NE, Casimiro MC, Li W, Ju X, Kim SH, Lisanti MP, Katzenellenbogen JA, Pestell RG. Cyclin D1 integrates estrogen-mediated DNA damage repair signaling. Cancer Research. 74: 3959-70. PMID 24830723 DOI: 10.1158/0008-5472.Can-13-3137 |
0.483 |
|
| 2014 |
Martinez-Outschoorn U, Sotgia F, Lisanti MP. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function. Seminars in Oncology. 41: 195-216. PMID 24787293 DOI: 10.1053/J.Seminoncol.2014.03.002 |
0.375 |
|
| 2014 |
Mercier I, Gonzales DM, Quann K, Pestell TG, Molchansky A, Sotgia F, Hulit J, Gandara R, Wang C, Pestell RG, Lisanti MP, Jasmin JF. CAPER, a novel regulator of human breast cancer progression. Cell Cycle (Georgetown, Tex.). 13: 1256-64. PMID 24621503 DOI: 10.4161/Cc.28156 |
0.577 |
|
| 2014 |
Martinez-Outschoorn UE, Lisanti MP, Sotgia F. Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth. Seminars in Cancer Biology. 25: 47-60. PMID 24486645 DOI: 10.1016/J.Semcancer.2014.01.005 |
0.373 |
|
| 2014 |
Lisanti MP, Tsirigos A, Pavlides S, Reeves KJ, Peiris-Pagès M, Chadwick AL, Sanchez-Alvarez R, Lamb R, Howell A, Martinez-Outschoorn UE, Sotgia F. JNK1 stress signaling is hyper-activated in high breast density and the tumor stroma: connecting fibrosis, inflammation, and stemness for cancer prevention. Cell Cycle (Georgetown, Tex.). 13: 580-99. PMID 24434780 DOI: 10.4161/Cc.27379 |
0.379 |
|
| 2014 |
Pavlides S, Gutierrez-Pajares JL, Iturrieta J, Lisanti MP, Frank PG. Endothelial caveolin-1 plays a major role in the development of atherosclerosis Cell and Tissue Research. 356: 147-157. PMID 24390341 DOI: 10.1007/S00441-013-1767-7 |
0.636 |
|
| 2014 |
Wu K, Chen K, Wang C, Jiao X, Wang L, Zhou J, Wang J, Li Z, Addya S, Sorensen PH, Lisanti MP, Quong A, Ertel A, Pestell RG. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation. Cancer Research. 74: 829-39. PMID 24335958 DOI: 10.1158/0008-5472.Can-13-2466 |
0.562 |
|
| 2014 |
Ju X, Casimiro MC, Gormley M, Meng H, Jiao X, Katiyar S, Crosariol M, Chen K, Wang M, Quong AA, Lisanti MP, Ertel A, Pestell RG. Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint. Cancer Research. 74: 508-19. PMID 24282282 DOI: 10.1158/0008-5472.Can-13-1313 |
0.499 |
|
| 2014 |
Mercier I, Gonzales DM, Quann K, Pestell TG, Molchansky A, Sotgia F, Hulit J, Gandara R, Wang C, Pestell RG, Lisanti MP, Jasmin JF. CAPER, a novel regulator of human breast cancer progression Cell Cycle. 13: 1256-1264. DOI: 10.4161/cc.28156 |
0.429 |
|
| 2014 |
Pavlides S, Gutierrez-Pajares JL, Katiyar S, Jasmin JF, Mercier I, Walters R, Pavlides C, Pestell RG, Lisanti MP, Frank PG. Caveolin-1 regulates the anti-atherogenic properties of macrophages Cell and Tissue Research. 358: 821-831. DOI: 10.1007/s00441-014-2008-4 |
0.62 |
|
| 2013 |
De Almeida CJG, Jasmin JF, Del Galdo F, Lisanti MP. Genetic ablation of caveolin-2 sensitizes mice to bleomycin-induced injury Cell Cycle. 12: 2248-2254. PMID 24067367 DOI: 10.4161/Cc.25335 |
0.342 |
|
| 2013 |
Danilo C, Gutierrez-Pajares JL, Mainieri MA, Mercier I, Lisanti MP, Frank PG. Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development Breast Cancer Research. 15. PMID 24060386 DOI: 10.1186/Bcr3483 |
0.819 |
|
| 2013 |
Lisanti MP, Sotgia F, Pestell RG, Howell A, Martinez-Outschoorn UE. Stromal glycolysis and MCT4 are hallmarks of DCIS progression to invasive breast cancer. Cell Cycle (Georgetown, Tex.). 12: 2935-6. PMID 23989616 DOI: 10.4161/Cc.26280 |
0.483 |
|
| 2013 |
Martinez-Outschoorn UE, Whitaker-Menezes D, Valsecchi M, Martinez-Cantarin MP, Dulau-Florea A, Gong J, Howell A, Flomenberg N, Pestell RG, Wagner J, Arana-Yi C, Sharma M, Sotgia F, Lisanti MP. Reverse Warburg effect in a patient with aggressive B-cell lymphoma: is lactic acidosis a paraneoplastic syndrome? Seminars in Oncology. 40: 403-18. PMID 23972703 DOI: 10.1053/J.Seminoncol.2013.04.016 |
0.459 |
|
| 2013 |
Chadwick AL, Howell A, Sotgia F, Lisanti MP. Carbonic anhydrase 9 (CA9) and redox signaling in cancer-associated fibroblasts: therapeutic implications. Cell Cycle (Georgetown, Tex.). 12: 2534-5. PMID 23907127 DOI: 10.4161/Cc.25842 |
0.418 |
|
| 2013 |
Sotgia F, Martinez-Outschoorn UE, Lisanti MP. Cancer metabolism: new validated targets for drug discovery. Oncotarget. 4: 1309-16. PMID 23896568 DOI: 10.18632/Oncotarget.1182 |
0.356 |
|
| 2013 |
Casimiro MC, Wang C, Li Z, Di Sante G, Willmart NE, Addya S, Chen L, Liu Y, Lisanti MP, Pestell RG. Cyclin D1 determines estrogen signaling in the mammary gland in vivo. Molecular Endocrinology (Baltimore, Md.). 27: 1415-28. PMID 23864650 DOI: 10.1210/Me.2013-1065 |
0.516 |
|
| 2013 |
Lisanti MP, Martinez-Outschoorn UE, Sotgia F. Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery. Cell Cycle (Georgetown, Tex.). 12: 2723-32. PMID 23860382 DOI: 10.4161/Cc.25695 |
0.387 |
|
| 2013 |
Martinez-Outschoorn UE, Curry JM, Ko YH, Lin Z, Tuluc M, Cognetti D, Birbe RC, Pribitkin E, Bombonati A, Pestell RG, Howell A, Sotgia F, Lisanti MP. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4. Cell Cycle (Georgetown, Tex.). 12: 2580-97. PMID 23860378 DOI: 10.4161/Cc.25510 |
0.542 |
|
| 2013 |
Chen K, Wu K, Gormley M, Ertel A, Wang J, Zhang W, Zhou J, Disante G, Li Z, Rui H, Quong AA, McMahon SB, Deng H, Lisanti MP, Wang C, et al. Acetylation of the cell-fate factor dachshund determines p53 binding and signaling modules in breast cancer. Oncotarget. 4: 923-35. PMID 23798621 DOI: 10.18632/Oncotarget.1094 |
0.511 |
|
| 2013 |
Addabbo F, Chen Q, Patel DP, Rabadi M, Ratliff B, Zhang F, Jasmin JF, Wolin M, Lisanti M, Gross SS, Goligorsky MS. Glutamine supplementation alleviates vasculopathy and corrects metabolic profile in an in vivo model of endothelial cell dysfunction. Plos One. 8: e65458. PMID 23776484 DOI: 10.1371/Journal.Pone.0065458 |
0.339 |
|
| 2013 |
Ayala G, Morello M, Frolov A, You S, Li R, Rosati F, Bartolucci G, Danza G, Adam RM, Thompson TC, Lisanti MP, Freeman MR, Di Vizio D. Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression. The Journal of Pathology. 231: 77-87. PMID 23729330 DOI: 10.1002/Path.4217 |
0.367 |
|
| 2013 |
Lima H, Jacobson LS, Goldberg MF, Chandran K, Diaz-Griffero F, Lisanti MP, Brojatsch J. Role of lysosome rupture in controlling Nlrp3 signaling and necrotic cell death. Cell Cycle (Georgetown, Tex.). 12: 1868-78. PMID 23708522 DOI: 10.4161/Cc.24903 |
0.315 |
|
| 2013 |
Saleh AD, Simone BA, Palazzo J, Savage JE, Sano Y, Dan T, Jin L, Champ CE, Zhao S, Lim M, Sotgia F, Camphausen K, Pestell RG, Mitchell JB, Lisanti MP, et al. Caloric restriction augments radiation efficacy in breast cancer. Cell Cycle (Georgetown, Tex.). 12: 1955-63. PMID 23708519 DOI: 10.4161/Cc.25016 |
0.506 |
|
| 2013 |
Volonte D, Liu Z, Musille PM, Stoppani E, Wakabayashi N, Di YP, Lisanti MP, Kensler TW, Galbiati F. Inhibition of nuclear factor-erythroid 2-related factor (Nrf2) by caveolin-1 promotes stress-induced premature senescence. Molecular Biology of the Cell. 24: 1852-62. PMID 23637463 DOI: 10.1091/Mbc.E12-09-0666 |
0.342 |
|
| 2013 |
Quann K, Gonzales DM, Mercier I, Wang C, Sotgia F, Pestell RG, Lisanti MP, Jasmin JF. Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide Cell Cycle. 12: 1510-1520. PMID 23598719 DOI: 10.4161/Cc.24497 |
0.553 |
|
| 2013 |
Araujo KP, Bonuccelli G, Duarte CN, Gaiad TP, Moreira DF, Feder D, Belizario JE, Miglino MA, Lisanti MP, Ambrosio CE. Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs. Plos One. 8: e61367. PMID 23579193 DOI: 10.1371/Journal.Pone.0061367 |
0.313 |
|
| 2013 |
Curry JM, Tuluc M, Whitaker-Menezes D, Ames JA, Anantharaman A, Butera A, Leiby B, Cognetti DM, Sotgia F, Lisanti MP, Martinez-Outschoorn UE. Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer. Cell Cycle (Georgetown, Tex.). 12: 1371-84. PMID 23574725 DOI: 10.4161/Cc.24092 |
0.355 |
|
| 2013 |
Avena P, Anselmo W, Whitaker-Menezes D, Wang C, Pestell RG, Lamb RS, Hulit J, Casaburi I, Andò S, Martinez-Outschoorn UE, Lisanti MP, Sotgia F. Compartment-specific activation of PPARγ governs breast cancer tumor growth, via metabolic reprogramming and symbiosis. Cell Cycle (Georgetown, Tex.). 12: 1360-70. PMID 23574724 DOI: 10.4161/Cc.24289 |
0.575 |
|
| 2013 |
Chen K, Wu K, Cai S, Zhang W, Zhou J, Wang J, Ertel A, Li Z, Rui H, Quong A, Lisanti MP, Tozeren A, Tanes C, Addya S, Gormley M, et al. Dachshund binds p53 to block the growth of lung adenocarcinoma cells. Cancer Research. 73: 3262-74. PMID 23492369 DOI: 10.1158/0008-5472.Can-12-3191 |
0.515 |
|
| 2013 |
Salem AF, Al-Zoubi MS, Whitaker-Menezes D, Martinez-Outschoorn UE, Lamb R, Hulit J, Howell A, Gandara R, Sartini M, Galbiati F, Bevilacqua G, Sotgia F, Lisanti MP. Cigarette smoke metabolically promotes cancer, via autophagy and premature aging in the host stromal microenvironment. Cell Cycle (Georgetown, Tex.). 12: 818-25. PMID 23388463 DOI: 10.4161/Cc.23722 |
0.304 |
|
| 2013 |
Champ CE, Baserga R, Mishra MV, Jin L, Sotgia F, Lisanti MP, Pestell RG, Dicker AP, Simone NL. Nutrient restriction and radiation therapy for cancer treatment: when less is more. The Oncologist. 18: 97-103. PMID 23299773 DOI: 10.1634/Theoncologist.2012-0164 |
0.496 |
|
| 2013 |
Al-Zoubi M, Salem AF, Martinez-Outschoorn UE, Whitaker-Menezes D, Lamb R, Hulit J, Howell A, Gandara R, Sartini M, Arafat H, Bevilacqua G, Sotgia F, Lisanti MP. Creating a tumor-resistant microenvironment: cell-mediated delivery of TNFα completely prevents breast cancer tumor formation in vivo. Cell Cycle (Georgetown, Tex.). 12: 480-90. PMID 23292149 DOI: 10.4161/Cc.23370 |
0.4 |
|
| 2013 |
Trimmer C, Bonuccelli G, Katiyar S, Sotgia F, Pestell RG, Lisanti MP, Capozza F. Cav1 suppresses tumor growth and metastasis in a murine model of cutaneous SCC through modulation of MAPK/AP-1 activation. The American Journal of Pathology. 182: 992-1004. PMID 23267770 DOI: 10.1016/J.Ajpath.2012.11.008 |
0.568 |
|
| 2013 |
Suk HY, Zhou C, Yang TT, Zhu H, Yu RY, Olabisi O, Yang X, Brancho D, Kim JY, Scherer PE, Frank PG, Lisanti MP, Calvert JW, Lefer DJ, Molkentin JD, et al. Ablation of calcineurin Aβ reveals hyperlipidemia and signaling cross-talks with phosphodiesterases. The Journal of Biological Chemistry. 288: 3477-88. PMID 23258544 DOI: 10.1074/Jbc.M112.419150 |
0.654 |
|
| 2013 |
Sanchez-Alvarez R, Martinez-Outschoorn UE, Lin Z, Lamb R, Hulit J, Howell A, Sotgia F, Rubin E, Lisanti MP. Ethanol exposure induces the cancer-associated fibroblast phenotype and lethal tumor metabolism: implications for breast cancer prevention. Cell Cycle (Georgetown, Tex.). 12: 289-301. PMID 23257780 DOI: 10.4161/Cc.23109 |
0.346 |
|
| 2013 |
Sanchez-Alvarez R, Martinez-Outschoorn UE, Lamb R, Hulit J, Howell A, Gandara R, Sartini M, Rubin E, Lisanti MP, Sotgia F. Mitochondrial dysfunction in breast cancer cells prevents tumor growth: understanding chemoprevention with metformin. Cell Cycle (Georgetown, Tex.). 12: 172-82. PMID 23257779 DOI: 10.4161/Cc.23058 |
0.354 |
|
| 2013 |
Ju X, Ertel A, Casimiro MC, Yu Z, Meng H, McCue PA, Walters R, Fortina P, Lisanti MP, Pestell RG. Novel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures. Cancer Research. 73: 978-89. PMID 23204233 DOI: 10.1158/0008-5472.Can-12-2133 |
0.491 |
|
| 2013 |
Li Z, Wermuth PJ, Benn BS, Lisanti MP, Jimenez SA. Caveolin-1 deficiency induces spontaneous endothelial-to-mesenchymal transition in murine pulmonary endothelial cells in vitro. The American Journal of Pathology. 182: 325-31. PMID 23195429 DOI: 10.1016/J.Ajpath.2012.10.022 |
0.312 |
|
| 2013 |
Pestell R, Chen K, Wu K, Gormley M, Ertel A, Zhang W, Zhou J, DiSante G, Li Z, Rui H, Quong A, McMahon S, Deng H, Lisanti M, Wang C. Abstract P5-11-04: Post-translational modification of the cell-fate factor Dachshund determines p53 binding and signaling modules in breast cancer Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P5-11-04 |
0.532 |
|
| 2013 |
Pestell R, Casimiro M, Crosariol M, Loro E, Dampier W, Sante GD, Ertel A, Yu Z, Saria E, Papanikolaou A, Li Z, Wang C, Addya S, Lisanti M, Fortina P, et al. Abstract P5-07-06: Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P5-07-06 |
0.537 |
|
| 2013 |
Pestell R, Tian L, Wang C, Soccio R, Hagen F, Chen E, Gormley M, Zhong Z, Ertel A, Addya S, Zhou J, Powell M, Xu P, Casimiro M, Lisanti M, et al. Abstract P2-06-02: Pparg deacetylation by SIRT1 determines breast tumor lipid synthesis and growth Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P2-06-02 |
0.54 |
|
| 2013 |
Pestell R, Wu K, Chen K, Wang C, Jiao X, Wang J, Cai S, Addya S, Sorensen P, Lisanti M, Quong A, Ertel A. Abstract P1-07-05: The cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P1-07-05 |
0.572 |
|
| 2012 |
Sotgia F, Martinez-Outschoorn UE, Lisanti MP. Genetic induction of the Warburg effect inhibits tumor growth. Oncotarget. 3: 1266-7. PMID 23175502 DOI: 10.18632/Oncotarget.739 |
0.364 |
|
| 2012 |
Martinez-Outschoorn UE, Balliet R, Lin Z, Whitaker-Menezes D, Birbe RC, Bombonati A, Pavlides S, Lamb R, Sneddon S, Howell A, Sotgia F, Lisanti MP. BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies. Cell Cycle (Georgetown, Tex.). 11: 4402-13. PMID 23172369 DOI: 10.4161/Cc.22776 |
0.384 |
|
| 2012 |
Sotgia F, Whitaker-Menezes D, Martinez-Outschoorn UE, Salem AF, Tsirigos A, Lamb R, Sneddon S, Hulit J, Howell A, Lisanti MP. Mitochondria "fuel" breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells. Cell Cycle (Georgetown, Tex.). 11: 4390-401. PMID 23172368 DOI: 10.4161/Cc.22777 |
0.347 |
|
| 2012 |
Martinez-Outschoorn UE, Lin Z, Whitaker-Menezes D, Howell A, Sotgia F, Lisanti MP. Ketone body utilization drives tumor growth and metastasis. Cell Cycle (Georgetown, Tex.). 11: 3964-71. PMID 23082722 DOI: 10.4161/Cc.22137 |
0.371 |
|
| 2012 |
Martinez-Outschoorn UE, Lin Z, Whitaker-Menezes D, Howell A, Lisanti MP, Sotgia F. Ketone bodies and two-compartment tumor metabolism: stromal ketone production fuels mitochondrial biogenesis in epithelial cancer cells. Cell Cycle (Georgetown, Tex.). 11: 3956-63. PMID 23082721 DOI: 10.4161/Cc.22136 |
0.376 |
|
| 2012 |
Salem AF, Whitaker-Menezes D, Howell A, Sotgia F, Lisanti MP. Mitochondrial biogenesis in epithelial cancer cells promotes breast cancer tumor growth and confers autophagy resistance. Cell Cycle (Georgetown, Tex.). 11: 4174-80. PMID 23070475 DOI: 10.4161/Cc.22376 |
0.367 |
|
| 2012 |
Martinez-Outschoorn UE, Balliet RM, Lin Z, Whitaker-Menezes D, Howell A, Sotgia F, Lisanti MP. Hereditary ovarian cancer and two-compartment tumor metabolism: epithelial loss of BRCA1 induces hydrogen peroxide production, driving oxidative stress and NFκB activation in the tumor stroma. Cell Cycle (Georgetown, Tex.). 11: 4152-66. PMID 23047606 DOI: 10.4161/Cc.22226 |
0.364 |
|
| 2012 |
Salem AF, Howell A, Sartini M, Sotgia F, Lisanti MP. Downregulation of stromal BRCA1 drives breast cancer tumor growth via upregulation of HIF-1α, autophagy and ketone body production. Cell Cycle (Georgetown, Tex.). 11: 4167-73. PMID 23047605 DOI: 10.4161/Cc.22316 |
0.411 |
|
| 2012 |
Bonuccelli G, Castello-Cros R, Capozza F, Martinez-Outschoorn UE, Lin Z, Tsirigos A, Xuanmao J, Whitaker-Menezes D, Howell A, Lisanti MP, Sotgia F. The milk protein α-casein functions as a tumor suppressor via activation of STAT1 signaling, effectively preventing breast cancer tumor growth and metastasis. Cell Cycle (Georgetown, Tex.). 11: 3972-82. PMID 23047602 DOI: 10.4161/Cc.22227 |
0.392 |
|
| 2012 |
Di Vizio D, Morello M, Dudley AC, Schow PW, Adam RM, Morley S, Mulholland D, Rotinen M, Hager MH, Insabato L, Moses MA, Demichelis F, Lisanti MP, Wu H, Klagsbrun M, et al. Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. The American Journal of Pathology. 181: 1573-84. PMID 23022210 DOI: 10.1016/J.Ajpath.2012.07.030 |
0.364 |
|
| 2012 |
Sirajuddin P, Das S, Ringer L, Rodriguez OC, Sivakumar A, Lee YC, Üren A, Fricke ST, Rood B, Ozcan A, Wang SS, Karam S, Yenugonda V, Salinas P, Petricoin E, ... ... Lisanti MP, et al. Quantifying the CDK inhibitor VMY-1-103's activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI. Cell Cycle (Georgetown, Tex.). 11: 3801-9. PMID 22983062 DOI: 10.4161/Cc.21988 |
0.307 |
|
| 2012 |
Yu Z, Pestell TG, Lisanti MP, Pestell RG. Cancer stem cells. The International Journal of Biochemistry & Cell Biology. 44: 2144-51. PMID 22981632 DOI: 10.1016/J.Biocel.2012.08.022 |
0.505 |
|
| 2012 |
Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, Ahn HJ, Ait-Mohamed O, Ait-Si-Ali S, Akematsu T, Akira S, ... ... Lisanti MP, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 8: 445-544. PMID 22966490 DOI: 10.4161/Auto.19496 |
0.53 |
|
| 2012 |
Capparelli C, Chiavarina B, Whitaker-Menezes D, Pestell TG, Pestell RG, Hulit J, Andò S, Howell A, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, "fueling" tumor growth via paracrine interactions, without an increase in neo-angiogenesis. Cell Cycle (Georgetown, Tex.). 11: 3599-610. PMID 22935696 DOI: 10.4161/Cc.21884 |
0.556 |
|
| 2012 |
Carito V, Bonuccelli G, Martinez-Outschoorn UE, Whitaker-Menezes D, Caroleo MC, Cione E, Howell A, Pestell RG, Lisanti MP, Sotgia F. Metabolic remodeling of the tumor microenvironment: migration stimulating factor (MSF) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth. Cell Cycle (Georgetown, Tex.). 11: 3403-14. PMID 22918248 DOI: 10.4161/Cc.21701 |
0.53 |
|
| 2012 |
Chiavarina B, Martinez-Outschoorn UE, Whitaker-Menezes D, Howell A, Tanowitz HB, Pestell RG, Sotgia F, Lisanti MP. Metabolic reprogramming and two-compartment tumor metabolism: opposing role(s) of HIF1α and HIF2α in tumor-associated fibroblasts and human breast cancer cells. Cell Cycle (Georgetown, Tex.). 11: 3280-9. PMID 22894905 DOI: 10.4161/Cc.21643 |
0.561 |
|
| 2012 |
Guido C, Whitaker-Menezes D, Lin Z, Pestell RG, Howell A, Zimmers TA, Casimiro MC, Aquila S, Ando' S, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth. Oncotarget. 3: 798-810. PMID 22878233 DOI: 10.18632/Oncotarget.574 |
0.513 |
|
| 2012 |
Guido C, Whitaker-Menezes D, Capparelli C, Balliet R, Lin Z, Pestell RG, Howell A, Aquila S, Andò S, Martinez-Outschoorn U, Sotgia F, Lisanti MP. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production. Cell Cycle (Georgetown, Tex.). 11: 3019-35. PMID 22874531 DOI: 10.4161/Cc.21384 |
0.549 |
|
| 2012 |
Guido C, Panza S, Santoro M, Avena P, Panno ML, Perrotta I, Giordano F, Casaburi I, Catalano S, De Amicis F, Sotgia F, Lisanti MP, Andò S, Aquila S. Estrogen receptor beta (ERβ) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter gene. Cell Cycle (Georgetown, Tex.). 11: 2911-21. PMID 22810004 DOI: 10.4161/Cc.21336 |
0.362 |
|
| 2012 |
Salem AF, Whitaker-Menezes D, Lin Z, Martinez-Outschoorn UE, Tanowitz HB, Al-Zoubi MS, Howell A, Pestell RG, Sotgia F, Lisanti MP. Two-compartment tumor metabolism: autophagy in the tumor microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells. Cell Cycle (Georgetown, Tex.). 11: 2545-56. PMID 22722266 DOI: 10.4161/Cc.20920 |
0.52 |
|
| 2012 |
Mercier I, Camacho J, Titchen K, Gonzales DM, Quann K, Bryant KG, Molchansky A, Milliman JN, Whitaker-Menezes D, Sotgia F, Jasmin JF, Schwarting R, Pestell RG, Blagosklonny MV, Lisanti MP. Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug. The American Journal of Pathology. 181: 278-93. PMID 22698676 DOI: 10.1016/J.Ajpath.2012.03.017 |
0.515 |
|
| 2012 |
Capparelli C, Whitaker-Menezes D, Guido C, Balliet R, Pestell TG, Howell A, Sneddon S, Pestell RG, Martinez-Outschoorn U, Lisanti MP, Sotgia F. CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth. Cell Cycle (Georgetown, Tex.). 11: 2272-84. PMID 22684333 DOI: 10.4161/Cc.20717 |
0.577 |
|
| 2012 |
Capparelli C, Guido C, Whitaker-Menezes D, Bonuccelli G, Balliet R, Pestell TG, Goldberg AF, Pestell RG, Howell A, Sneddon S, Birbe R, Tsirigos A, Martinez-Outschoorn U, Sotgia F, Lisanti MP. Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production. Cell Cycle (Georgetown, Tex.). 11: 2285-302. PMID 22684298 DOI: 10.4161/Cc.20718 |
0.553 |
|
| 2012 |
Esper L, Roman-Campos D, Lara A, Brant F, Castro LL, Barroso A, Araujo RR, Vieira LQ, Mukherjee S, Gomes ER, Rocha NN, Ramos IP, Lisanti MP, Campos CF, Arantes RM, et al. Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease. The American Journal of Pathology. 181: 130-40. PMID 22658486 DOI: 10.1016/J.Ajpath.2012.03.042 |
0.321 |
|
| 2012 |
Velasco-Velázquez M, Jiao X, De La Fuente M, Pestell TG, Ertel A, Lisanti MP, Pestell RG. CCR5 antagonist blocks metastasis of basal breast cancer cells. Cancer Research. 72: 3839-50. PMID 22637726 DOI: 10.1158/0008-5472.Can-11-3917 |
0.529 |
|
| 2012 |
Gazzerro E, Baldassari S, Giacomini C, Musante V, Fruscione F, La Padula V, Biancheri R, Scarfì S, Prada V, Sotgia F, Duncan ID, Zara F, Werner HB, Lisanti MP, Nobbio L, et al. Hyccin, the molecule mutated in the leukodystrophy hypomyelination and congenital cataract (HCC), is a neuronal protein. Plos One. 7: e32180. PMID 22461884 DOI: 10.1371/Journal.Pone.0032180 |
0.313 |
|
| 2012 |
Ørom UA, Lim MK, Savage JE, Jin L, Saleh AD, Lisanti MP, Simone NL. MicroRNA-203 regulates caveolin-1 in breast tissue during caloric restriction. Cell Cycle (Georgetown, Tex.). 11: 1291-5. PMID 22421148 DOI: 10.4161/Cc.19704 |
0.304 |
|
| 2012 |
Pavlides S, Gutierrez-Pajares JL, Danilo C, Lisanti MP, Frank PG. Atherosclerosis, caveolae and caveolin-1. Advances in Experimental Medicine and Biology. 729: 127-44. PMID 22411318 DOI: 10.1007/978-1-4614-1222-9_9 |
0.807 |
|
| 2012 |
Mercier I, Lisanti MP. Caveolin-1 and breast cancer: a new clinical perspective. Advances in Experimental Medicine and Biology. 729: 83-94. PMID 22411315 DOI: 10.1007/978-1-4614-1222-9_6 |
0.342 |
|
| 2012 |
Capozza F, Trimmer C, Castello-Cros R, Katiyar S, Whitaker-Menezes D, Follenzi A, Crosariol M, Llaverias G, Sotgia F, Pestell RG, Lisanti MP. Genetic ablation of Cav1 differentially affects melanoma tumor growth and metastasis in mice: role of Cav1 in Shh heterotypic signaling and transendothelial migration. Cancer Research. 72: 2262-74. PMID 22396494 DOI: 10.1158/0008-5472.Can-11-2593 |
0.574 |
|
| 2012 |
Sotgia F, Whitaker-Menezes D, Martinez-Outschoorn UE, Flomenberg N, Birbe RC, Witkiewicz AK, Howell A, Philp NJ, Pestell RG, Lisanti MP. Mitochondrial metabolism in cancer metastasis: visualizing tumor cell mitochondria and the "reverse Warburg effect" in positive lymph node tissue. Cell Cycle (Georgetown, Tex.). 11: 1445-54. PMID 22395432 DOI: 10.4161/Cc.19841 |
0.536 |
|
| 2012 |
Wang Y, Wang X, Jasmin JF, Lau WB, Li R, Yuan Y, Yi W, Chuprun K, Lisanti MP, Koch WJ, Gao E, Ma XL. Essential role of caveolin-3 in adiponectin signalsome formation and adiponectin cardioprotection. Arteriosclerosis, Thrombosis, and Vascular Biology. 32: 934-42. PMID 22328772 DOI: 10.1161/Atvbaha.111.242164 |
0.369 |
|
| 2012 |
Witkiewicz AK, Whitaker-Menezes D, Dasgupta A, Philp NJ, Lin Z, Gandara R, Sneddon S, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers. Cell Cycle (Georgetown, Tex.). 11: 1108-17. PMID 22313602 DOI: 10.4161/Cc.11.6.19530 |
0.368 |
|
| 2012 |
Ertel A, Tsirigos A, Whitaker-Menezes D, Birbe RC, Pavlides S, Martinez-Outschoorn UE, Pestell RG, Howell A, Sotgia F, Lisanti MP. Is cancer a metabolic rebellion against host aging? In the quest for immortality, tumor cells try to save themselves by boosting mitochondrial metabolism. Cell Cycle (Georgetown, Tex.). 11: 253-63. PMID 22234241 DOI: 10.4161/Cc.11.2.19006 |
0.508 |
|
| 2012 |
Neill T, Painter H, Buraschi S, Owens RT, Lisanti MP, Schaefer L, Iozzo RV. Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1α, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. The Journal of Biological Chemistry. 287: 5492-506. PMID 22194599 DOI: 10.1074/Jbc.M111.283499 |
0.345 |
|
| 2012 |
Katiyar S, Jiao X, Addya S, Ertel A, Covarrubias Y, Rose V, Casimiro MC, Zhou J, Lisanti MP, Nasim T, Fortina P, Pestell RG. Mammary gland selective excision of c-jun identifies its role in mRNA splicing. Cancer Research. 72: 1023-34. PMID 22174367 DOI: 10.1158/0008-5472.Can-11-3647 |
0.5 |
|
| 2012 |
Sotgia F, Martinez-Outschoorn UE, Howell A, Pestell RG, Pavlides S, Lisanti MP. Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms. Annual Review of Pathology. 7: 423-67. PMID 22077552 DOI: 10.1146/Annurev-Pathol-011811-120856 |
0.566 |
|
| 2012 |
Pavlides S, Vera I, Gandara R, Sneddon S, Pestell RG, Mercier I, Martinez-Outschoorn UE, Whitaker-Menezes D, Howell A, Sotgia F, Lisanti MP. Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. Antioxidants & Redox Signaling. 16: 1264-84. PMID 21883043 DOI: 10.1089/Ars.2011.4243 |
0.494 |
|
| 2012 |
Danilo C, Mainieri MA, Lisanti MP, Frank PG. Abstract 4123: Cholesterol and breast cancer Cancer Research. 72: 4123-4123. DOI: 10.1158/1538-7445.Am2012-4123 |
0.802 |
|
| 2012 |
Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Power surge: Supporting cells "fuel" cancer cell mitochondria Cell Metabolism. 15: 4-5. DOI: 10.1016/J.Cmet.2011.12.011 |
0.332 |
|
| 2012 |
Jasmin JF, Frank PG, Lisanti MP. Preface Advances in Experimental Medicine and Biology. 729: v-vi. |
0.496 |
|
| 2011 |
Ko YH, Lin Z, Flomenberg N, Pestell RG, Howell A, Sotgia F, Lisanti MP, Martinez-Outschoorn UE. Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells: implications for preventing chemotherapy resistance. Cancer Biology & Therapy. 12: 1085-97. PMID 22236876 DOI: 10.4161/Cbt.12.12.18671 |
0.561 |
|
| 2011 |
Chiavarina B, Whitaker-Menezes D, Martinez-Outschoorn UE, Witkiewicz AK, Birbe R, Howell A, Pestell RG, Smith J, Daniel R, Sotgia F, Lisanti MP. Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth. Cancer Biology & Therapy. 12: 1101-13. PMID 22236875 DOI: 10.4161/Cbt.12.12.18703 |
0.572 |
|
| 2011 |
Wu KN, Queenan M, Brody JR, Potoczek M, Sotgia F, Lisanti MP, Witkiewicz AK. Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival. Cell Cycle (Georgetown, Tex.). 10: 4250-5. PMID 22134245 DOI: 10.4161/Cc.10.24.18551 |
0.337 |
|
| 2011 |
Whitaker-Menezes D, Martinez-Outschoorn UE, Flomenberg N, Birbe RC, Witkiewicz AK, Howell A, Pavlides S, Tsirigos A, Ertel A, Pestell RG, Broda P, Minetti C, Lisanti MP, Sotgia F. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue. Cell Cycle (Georgetown, Tex.). 10: 4047-64. PMID 22134189 DOI: 10.4161/Cc.10.23.18151 |
0.553 |
|
| 2011 |
Balliet RM, Capparelli C, Guido C, Pestell TG, Martinez-Outschoorn UE, Lin Z, Whitaker-Menezes D, Chiavarina B, Pestell RG, Howell A, Sotgia F, Lisanti MP. Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: understanding the aging and cancer connection. Cell Cycle (Georgetown, Tex.). 10: 4065-73. PMID 22129993 DOI: 10.4161/Cc.10.23.18254 |
0.53 |
|
| 2011 |
Freeman MR, Kim J, Lisanti MP, Di Vizio D. A metabolic perturbation by U0126 identifies a role for glutamine in resveratrol-induced cell death. Cancer Biology & Therapy. 12: 966-77. PMID 22108021 DOI: 10.4161/Cbt.12.11.18136 |
0.353 |
|
| 2011 |
Martinez-Outschoorn UE, Goldberg A, Lin Z, Ko YH, Flomenberg N, Wang C, Pavlides S, Pestell RG, Howell A, Sotgia F, Lisanti MP. Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells. Cancer Biology & Therapy. 12: 924-38. PMID 22041887 DOI: 10.4161/Cbt.12.10.17780 |
0.531 |
|
| 2011 |
Salem AF, Bonuccelli G, Bevilacqua G, Arafat H, Pestell RG, Sotgia F, Lisanti MP. Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition. Cell Cycle (Georgetown, Tex.). 10: 3692-700. PMID 22041584 DOI: 10.4161/Cc.10.21.17895 |
0.57 |
|
| 2011 |
Martinez-Outschoorn UE, Pestell RG, Howell A, Tykocinski ML, Nagajyothi F, Machado FS, Tanowitz HB, Sotgia F, Lisanti MP. Energy transfer in "parasitic" cancer metabolism: mitochondria are the powerhouse and Achilles' heel of tumor cells. Cell Cycle (Georgetown, Tex.). 10: 4208-16. PMID 22033146 DOI: 10.4161/Cc.10.24.18487 |
0.534 |
|
| 2011 |
Huang H, Ma YF, Bao Y, Lee H, Lisanti MP, Tanowitz HB, Weiss LM. Molecular cloning and characterization of mitogen-activated protein kinase 2 in Toxoplasma gondii. Cell Cycle (Georgetown, Tex.). 10: 3519-26. PMID 22030559 DOI: 10.4161/Cc.10.20.17791 |
0.558 |
|
| 2011 |
Sotgia F, Martinez-Outschoorn UE, Pavlides S, Howell A, Pestell RG, Lisanti MP. Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment. Breast Cancer Research : Bcr. 13: 213. PMID 21867571 DOI: 10.1186/Bcr2892 |
0.536 |
|
| 2011 |
Chi Y, Min J, Jasmin JF, Lisanti MP, Chang YT, Schuster VL. Development of a high-affinity inhibitor of the prostaglandin transporter. The Journal of Pharmacology and Experimental Therapeutics. 339: 633-41. PMID 21849625 DOI: 10.1124/Jpet.111.181354 |
0.305 |
|
| 2011 |
Martinez-Outschoorn UE, Lin Z, Trimmer C, Flomenberg N, Wang C, Pavlides S, Pestell RG, Howell A, Sotgia F, Lisanti MP. Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors. Cell Cycle (Georgetown, Tex.). 10: 2504-20. PMID 21778829 DOI: 10.4161/Cc.10.15.16585 |
0.52 |
|
| 2011 |
Martinez-Outschoorn UE, Lin Z, Ko YH, Goldberg AF, Flomenberg N, Wang C, Pavlides S, Pestell RG, Howell A, Sotgia F, Lisanti MP. Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells. Cell Cycle (Georgetown, Tex.). 10: 2521-8. PMID 21768775 DOI: 10.4161/Cc.10.15.16584 |
0.532 |
|
| 2011 |
Lisanti MP, Martinez-Outschoorn UE, Lin Z, Pavlides S, Whitaker-Menezes D, Pestell RG, Howell A, Sotgia F. Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: the seed and soil also needs "fertilizer". Cell Cycle (Georgetown, Tex.). 10: 2440-9. PMID 21734470 DOI: 10.4161/Cc.10.15.16870 |
0.508 |
|
| 2011 |
Ren G, Jacob RF, Kaulin Y, Dimuzio P, Xie Y, Mason RP, Tint GS, Steiner RD, Roullet JB, Merkens L, Whitaker-Menezes D, Frank PG, Lisanti MP, Cox RH, Tulenko TN. Alterations in membrane caveolae and BKCa channel activity in skin fibroblasts in Smith-Lemli-Opitz syndrome. Molecular Genetics and Metabolism. 104: 346-55. PMID 21724437 DOI: 10.1016/J.Ymgme.2011.04.019 |
0.63 |
|
| 2011 |
Castello-Cros R, Whitaker-Menezes D, Molchansky A, Purkins G, Soslowsky LJ, Beason DP, Sotgia F, Iozzo RV, Lisanti MP. Scleroderma-like properties of skin from caveolin-1-deficient mice: implications for new treatment strategies in patients with fibrosis and systemic sclerosis. Cell Cycle (Georgetown, Tex.). 10: 2140-50. PMID 21670602 DOI: 10.4161/Cc.10.13.16227 |
0.347 |
|
| 2011 |
de Almeida CJ, Witkiewicz AK, Jasmin JF, Tanowitz HB, Sotgia F, Frank PG, Lisanti MP. Caveolin-2-deficient mice show increased sensitivity to endotoxemia. Cell Cycle (Georgetown, Tex.). 10: 2151-61. PMID 21670588 DOI: 10.4161/Cc.10.13.16234 |
0.651 |
|
| 2011 |
Lisanti MP, Martinez-Outschoorn UE, Pavlides S, Whitaker-Menezes D, Pestell RG, Howell A, Sotgia F. Accelerated aging in the tumor microenvironment: connecting aging, inflammation and cancer metabolism with personalized medicine. Cell Cycle (Georgetown, Tex.). 10: 2059-63. PMID 21654190 DOI: 10.4161/Cc.10.13.16233 |
0.521 |
|
| 2011 |
Castello-Cros R, Bonuccelli G, Molchansky A, Capozza F, Witkiewicz AK, Birbe RC, Howell A, Pestell RG, Whitaker-Menezes D, Sotgia F, Lisanti MP. Matrix remodeling stimulates stromal autophagy, "fueling" cancer cell mitochondrial metabolism and metastasis. Cell Cycle (Georgetown, Tex.). 10: 2021-34. PMID 21646868 DOI: 10.4161/Cc.10.12.16002 |
0.577 |
|
| 2011 |
Velasco-Velázquez MA, Popov VM, Lisanti MP, Pestell RG. The role of breast cancer stem cells in metastasis and therapeutic implications. The American Journal of Pathology. 179: 2-11. PMID 21640330 DOI: 10.1016/J.Ajpath.2011.03.005 |
0.518 |
|
| 2011 |
Sotgia F, Martinez-Outschoorn UE, Lisanti MP. Mitochondrial oxidative stress drives tumor progression and metastasis: Should we use antioxidants as a key component of cancer treatment and prevention? Bmc Medicine. 9. PMID 21605374 DOI: 10.1186/1741-7015-9-62 |
0.308 |
|
| 2011 |
Bryant KG, Camacho J, Jasmin JF, Wang C, Addya S, Casimiro MC, Fortina P, Balasubramaniam S, Knudsen KE, Schwarting R, Lisanti MP, Mercier I. Caveolin-1 overexpression enhances androgen-dependent growth and proliferation in the mouse prostate. The International Journal of Biochemistry & Cell Biology. 43: 1318-29. PMID 21601007 DOI: 10.1016/J.Biocel.2011.04.019 |
0.342 |
|
| 2011 |
Martinez-Outschoorn UE, Whitaker-Menezes D, Lin Z, Flomenberg N, Howell A, Pestell RG, Lisanti MP, Sotgia F. Cytokine production and inflammation drive autophagy in the tumor microenvironment: role of stromal caveolin-1 as a key regulator. Cell Cycle (Georgetown, Tex.). 10: 1784-93. PMID 21566463 DOI: 10.4161/Cc.10.11.15674 |
0.546 |
|
| 2011 |
Whitaker-Menezes D, Martinez-Outschoorn UE, Lin Z, Ertel A, Flomenberg N, Witkiewicz AK, Birbe RC, Howell A, Pavlides S, Gandara R, Pestell RG, Sotgia F, Philp NJ, Lisanti MP. Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle (Georgetown, Tex.). 10: 1772-83. PMID 21558814 DOI: 10.4161/Cc.10.11.15659 |
0.554 |
|
| 2011 |
Witkiewicz AK, Kline J, Queenan M, Brody JR, Tsirigos A, Bilal E, Pavlides S, Ertel A, Sotgia F, Lisanti MP. Molecular profiling of a lethal tumor microenvironment, as defined by stromal caveolin-1 status in breast cancers. Cell Cycle (Georgetown, Tex.). 10: 1794-809. PMID 21521946 DOI: 10.4161/Cc.10.11.15675 |
0.398 |
|
| 2011 |
Martinez-Outschoorn UE, Pavlides S, Sotgia F, Lisanti MP. Mitochondrial biogenesis drives tumor cell proliferation American Journal of Pathology. 178: 1949-1952. PMID 21514412 DOI: 10.1016/J.Ajpath.2011.03.002 |
0.343 |
|
| 2011 |
Martinez-Outschoorn UE, Prisco M, Ertel A, Tsirigos A, Lin Z, Pavlides S, Wang C, Flomenberg N, Knudsen ES, Howell A, Pestell RG, Sotgia F, Lisanti MP. Ketones and lactate increase cancer cell "stemness," driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics. Cell Cycle (Georgetown, Tex.). 10: 1271-86. PMID 21512313 DOI: 10.4161/Cc.10.8.15330 |
0.543 |
|
| 2011 |
Soares MB, Lima RS, Souza BS, Vasconcelos JF, Rocha LL, Dos Santos RR, Iacobas S, Goldenberg RC, Lisanti MP, Iacobas DA, Tanowitz HB, Spray DC, Campos de Carvalho AC. Reversion of gene expression alterations in hearts of mice with chronic chagasic cardiomyopathy after transplantation of bone marrow cells. Cell Cycle (Georgetown, Tex.). 10: 1448-55. PMID 21467843 DOI: 10.4161/Cc.10.9.15487 |
0.308 |
|
| 2011 |
Janowski E, Jiao X, Katiyar S, Lisanti MP, Liu M, Pestell RG, Morad M. c-Jun is required for TGF-β-mediated cellular migration via nuclear Ca²⺠signaling. The International Journal of Biochemistry & Cell Biology. 43: 1104-13. PMID 21447400 DOI: 10.1016/J.Biocel.2011.03.011 |
0.507 |
|
| 2011 |
Crist RC, Roth JJ, Lisanti MP, Siracusa LD, Buchberg AM. Identification of Mom12 and Mom13, two novel modifier loci of Apc (Min) -mediated intestinal tumorigenesis. Cell Cycle (Georgetown, Tex.). 10: 1092-9. PMID 21386660 DOI: 10.4161/Cc.10.7.15089 |
0.312 |
|
| 2011 |
Tanowitz HB, Mukhopadhyay A, Ashton AW, Lisanti MP, Machado FS, Weiss LM, Mukherjee S. Microarray analysis of the mammalian thromboxane receptor-Trypanosoma cruzi interaction. Cell Cycle (Georgetown, Tex.). 10: 1132-43. PMID 21364319 DOI: 10.4161/Cc.10.7.15207 |
0.36 |
|
| 2011 |
Feiner EC, Chung P, Jasmin JF, Zhang J, Whitaker-Menezes D, Myers V, Song J, Feldman EW, Funakoshi H, Degeorge BR, Yelamarty RV, Koch WJ, Lisanti MP, McTiernan CF, Cheung JY, et al. Left ventricular dysfunction in murine models of heart failure and in failing human heart is associated with a selective decrease in the expression of caveolin-3. Journal of Cardiac Failure. 17: 253-63. PMID 21362533 DOI: 10.1016/J.Cardfail.2010.10.008 |
0.304 |
|
| 2011 |
Martinez-Outschoorn UE, Pavlides S, Howell A, Pestell RG, Tanowitz HB, Sotgia F, Lisanti MP. Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment. The International Journal of Biochemistry & Cell Biology. 43: 1045-51. PMID 21300172 DOI: 10.1016/J.Biocel.2011.01.023 |
0.542 |
|
| 2011 |
Jasmin JF, Rengo G, Lymperopoulos A, Gupta R, Eaton GJ, Quann K, Gonzales DM, Mercier I, Koch WJ, Lisanti MP. Caveolin-1 deficiency exacerbates cardiac dysfunction and reduces survival in mice with myocardial infarction. American Journal of Physiology. Heart and Circulatory Physiology. 300: H1274-81. PMID 21297026 DOI: 10.1152/Ajpheart.01173.2010 |
0.305 |
|
| 2011 |
Thomas NM, Jasmin JF, Lisanti MP, Iacobas DA. Sex differences in expression and subcellular localization of heart rhythm determinant proteins Biochemical and Biophysical Research Communications. 406: 117-122. PMID 21296051 DOI: 10.1016/J.Bbrc.2011.02.006 |
0.316 |
|
| 2011 |
Wang C, Tai Y, Lisanti MP, Liao DJ. c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis. Cancer Biology & Therapy. 11: 615-26. PMID 21278493 DOI: 10.4161/Cbt.11.7.14688 |
0.358 |
|
| 2011 |
Llaverias G, Danilo C, Mercier I, Daumer K, Capozza F, Williams TM, Sotgia F, Lisanti MP, Frank PG. Role of cholesterol in the development and progression of breast cancer. The American Journal of Pathology. 178: 402-12. PMID 21224077 DOI: 10.1016/J.Ajpath.2010.11.005 |
0.799 |
|
| 2011 |
Meng H, Tian L, Zhou J, Li Z, Jiao X, Li WW, Plomann M, Xu Z, Lisanti MP, Wang C, Pestell RG. PACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1b. Cell Cycle (Georgetown, Tex.). 10: 73-81. PMID 21200149 DOI: 10.4161/Cc.10.1.14243 |
0.5 |
|
| 2011 |
Wang C, Lisanti MP, Liao DJ. Reviewing once more the c-myc and Ras collaboration: Converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology Cell Cycle. 10: 57-67. PMID 21200143 DOI: 10.4161/Cc.10.1.14449 |
0.333 |
|
| 2011 |
Trimmer C, Sotgia F, Whitaker-Menezes D, Balliet RM, Eaton G, Martinez-Outschoorn UE, Pavlides S, Howell A, Iozzo RV, Pestell RG, Scherer PE, Capozza F, Lisanti MP. Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts. Cancer Biology & Therapy. 11: 383-94. PMID 21150282 DOI: 10.4161/Cbt.11.4.14101 |
0.555 |
|
| 2011 |
Rivadeneira D, Mercier I, Lisanti MP, Witkiewicz A, Knudsen ES. Abstract 233: Crosstalk of Her2 signaling and cell cycle control in the response to targeted therapeutics in breast cancer Cancer Research. 71: 233-233. DOI: 10.1158/1538-7445.Am2011-233 |
0.402 |
|
| 2011 |
Witkiewicz AK, Kline J, Queenan M, Brody J, Sotgia F, Tsirigos A, Lisanti MP. Abstract 1510: Transcriptional profiling of a lethal breast cancer tumor microenvironment Cancer Research. 71: 1510-1510. DOI: 10.1158/1538-7445.Am2011-1510 |
0.399 |
|
| 2011 |
Trimmer C, Katiyar S, Pestell RG, Lisanti MP, Capozza F. Abstract 1083: Caveolin-1 in cutaneous squamous cell carcinoma development Cancer Research. 71: 1083-1083. DOI: 10.1158/1538-7445.Am2011-1083 |
0.41 |
|
| 2010 |
Liu M, Sakamaki T, Casimiro MC, Willmarth NE, Quong AA, Ju X, Ojeifo J, Jiao X, Yeow WS, Katiyar S, Shirley LA, Joyce D, Lisanti MP, Albanese C, Pestell RG. The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion. Cancer Research. 70: 10464-73. PMID 21159656 DOI: 10.1158/0008-5472.Can-10-0732 |
0.515 |
|
| 2010 |
Llaverias G, Danilo C, Wang Y, Witkiewicz AK, Daumer K, Lisanti MP, Frank PG. A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer. The American Journal of Pathology. 177: 3180-91. PMID 21088217 DOI: 10.2353/Ajpath.2010.100568 |
0.789 |
|
| 2010 |
Martinez-Outschoorn UE, Whitaker-Menezes D, Pavlides S, Chiavarina B, Bonuccelli G, Casey T, Tsirigos A, Migneco G, Witkiewicz A, Balliet R, Mercier I, Wang C, Flomenberg N, Howell A, Lin Z, ... ... Lisanti MP, et al. The autophagic tumor stroma model of cancer or "battery-operated tumor growth": A simple solution to the autophagy paradox. Cell Cycle (Georgetown, Tex.). 9: 4297-306. PMID 21051947 DOI: 10.4161/Cc.9.21.13817 |
0.53 |
|
| 2010 |
Chiavarina B, Whitaker-Menezes D, Migneco G, Martinez-Outschoorn UE, Pavlides S, Howell A, Tanowitz HB, Casimiro MC, Wang C, Pestell RG, Grieshaber P, Caro J, Sotgia F, Lisanti MP. HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis. Cell Cycle (Georgetown, Tex.). 9: 3534-51. PMID 20864819 DOI: 10.4161/Cc.9.17.12908 |
0.557 |
|
| 2010 |
Pavlides S, Tsirigos A, Migneco G, Whitaker-Menezes D, Chiavarina B, Flomenberg N, Frank PG, Casimiro MC, Wang C, Pestell RG, Martinez-Outschoorn UE, Howell A, Sotgia F, Lisanti MP. The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle (Georgetown, Tex.). 9: 3485-505. PMID 20861672 DOI: 10.4161/Cc.9.17.12721 |
0.691 |
|
| 2010 |
Lisanti MP, Martinez-Outschoorn UE, Chiavarina B, Pavlides S, Whitaker-Menezes D, Tsirigos A, Witkiewicz A, Lin Z, Balliet R, Howell A, Sotgia F. Understanding the "lethal" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment. Cancer Biology & Therapy. 10: 537-42. PMID 20861671 DOI: 10.4161/Cbt.10.6.13370 |
0.368 |
|
| 2010 |
Martinez-Outschoorn UE, Trimmer C, Lin Z, Whitaker-Menezes D, Chiavarina B, Zhou J, Wang C, Pavlides S, Martinez-Cantarin MP, Capozza F, Witkiewicz AK, Flomenberg N, Howell A, Pestell RG, Caro J, ... Lisanti MP, et al. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment. Cell Cycle (Georgetown, Tex.). 9: 3515-33. PMID 20855962 DOI: 10.4161/Cc.9.17.12928 |
0.559 |
|
| 2010 |
Bonuccelli G, Tsirigos A, Whitaker-Menezes D, Pavlides S, Pestell RG, Chiavarina B, Frank PG, Flomenberg N, Howell A, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle (Georgetown, Tex.). 9: 3506-14. PMID 20818174 DOI: 10.4161/Cc.9.17.12731 |
0.714 |
|
| 2010 |
Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB, Chiavarina B, Pavlides S, Wang C, Whitaker-Menezes D, Daumer KM, Lin Z, Witkiewicz AK, Flomenberg N, Howell A, Pestell RG, Knudsen ES, Sotgia F, ... Lisanti MP, et al. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle (Georgetown, Tex.). 9: 3256-76. PMID 20814239 DOI: 10.4161/Cc.9.16.12553 |
0.529 |
|
| 2010 |
Trimmer C, Whitaker-Menezes D, Bonuccelli G, Milliman JN, Daumer KM, Aplin AE, Pestell RG, Sotgia F, Lisanti MP, Capozza F. CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway. Cancer Research. 70: 7489-99. PMID 20709760 DOI: 10.1158/0008-5472.Can-10-0900 |
0.595 |
|
| 2010 |
Zhu H, Suk HY, Yu RY, Brancho D, Olabisi O, Yang TT, Yang X, Zhang J, Moussaif M, Durand JL, Jelicks LA, Kim JY, Scherer PE, Frank PG, Lisanti MP, et al. Evolutionarily conserved role of calcineurin in phosphodegron-dependent degradation of phosphodiesterase 4D. Molecular and Cellular Biology. 30: 4379-90. PMID 20647544 DOI: 10.1128/Mcb.01193-09 |
0.621 |
|
| 2010 |
Bao Y, Weiss LM, Ma YF, Lisanti MP, Tanowitz HB, Das BC, Zheng R, Huang H. Molecular cloning and characterization of mitogen-activated protein kinase 2 in Trypanosoma cruzi. Cell Cycle (Georgetown, Tex.). 9: 2888-96. PMID 20603604 DOI: 10.4161/Cc.9.14.12372 |
0.371 |
|
| 2010 |
Ringer L, Sirajuddin P, Yenugonda VM, Ghosh A, Divito K, Trabosh V, Patel Y, Brophy A, Grindrod S, Lisanti MP, Rosenthal D, Brown ML, Avantaggiati ML, Rodriguez O, Albanese C. VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells. Cancer Biology & Therapy. 10: 320-5. PMID 20574155 DOI: 10.4161/Cbt.10.4.12208 |
0.368 |
|
| 2010 |
Migneco G, Whitaker-Menezes D, Chiavarina B, Castello-Cros R, Pavlides S, Pestell RG, Fatatis A, Flomenberg N, Tsirigos A, Howell A, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling. Cell Cycle (Georgetown, Tex.). 9: 2412-22. PMID 20562527 DOI: 10.4161/Cc.9.12.11989 |
0.556 |
|
| 2010 |
Martinez-Outschoorn UE, Pavlides S, Whitaker-Menezes D, Daumer KM, Milliman JN, Chiavarina B, Migneco G, Witkiewicz AK, Martinez-Cantarin MP, Flomenberg N, Howell A, Pestell RG, Lisanti MP, Sotgia F. Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors. Cell Cycle (Georgetown, Tex.). 9: 2423-33. PMID 20562526 DOI: 10.4161/Cc.9.12.12048 |
0.55 |
|
| 2010 |
Ratliff BB, Singh N, Yasuda K, Park HC, Addabbo F, Ghaly T, Rajdev M, Jasmin JF, Plotkin M, Lisanti MP, Goligorsky MS. Mesenchymal stem cells, used as bait, disclose tissue binding sites: A tool in the search for the niche? American Journal of Pathology. 177: 873-883. PMID 20558574 DOI: 10.2353/Ajpath.2010.090984 |
0.32 |
|
| 2010 |
Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, Wang C, Fortina P, Addya S, Pestell RG, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation. Cell Cycle (Georgetown, Tex.). 9: 2201-19. PMID 20519932 DOI: 10.4161/Cc.9.11.11848 |
0.72 |
|
| 2010 |
Bonuccelli G, Whitaker-Menezes D, Castello-Cros R, Pavlides S, Pestell RG, Fatatis A, Witkiewicz AK, Vander Heiden MG, Migneco G, Chiavarina B, Frank PG, Capozza F, Flomenberg N, Martinez-Outschoorn UE, Sotgia F, ... Lisanti MP, et al. The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts. Cell Cycle (Georgetown, Tex.). 9: 1960-71. PMID 20495363 DOI: 10.4161/Cc.9.10.11601 |
0.726 |
|
| 2010 |
Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, Wang C, Pestell RG, Martinez-Outschoorn UE, Howell A, Sotgia F, Lisanti MP. Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling". Aging. 2: 185-99. PMID 20442453 DOI: v2/n4/full/100134.html |
0.689 |
|
| 2010 |
Witkiewicz AK, Dasgupta A, Sammons S, Er O, Potoczek MB, Guiles F, Sotgia F, Brody JR, Mitchell EP, Lisanti MP. Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers. Cancer Biology & Therapy. 10: 135-43. PMID 20431349 DOI: 10.4161/Cbt.10.2.11983 |
0.305 |
|
| 2010 |
Yu Z, Willmarth NE, Zhou J, Katiyar S, Wang M, Liu Y, McCue PA, Quong AA, Lisanti MP, Pestell RG. microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proceedings of the National Academy of Sciences of the United States of America. 107: 8231-6. PMID 20406904 DOI: 10.1073/Pnas.1002080107 |
0.553 |
|
| 2010 |
Vissapragada S, Ghosh A, Ringer L, Salinas P, Brophy A, Peaceman D, Kallakury B, Banerjee PP, Fricke ST, Helfrich W, Lee YC, Pestell R, Scherer P, Tanowitz HB, Avantaggiati ML, ... ... Lisanti MP, et al. Dietary n-3 polyunsaturated fatty acids fail to reduce prostate tumorigenesis in the PB-ErbB-2 x Pten(+/-) preclinical mouse model. Cell Cycle (Georgetown, Tex.). 9: 1824-9. PMID 20404514 DOI: 10.4161/Cc.9.9.11542 |
0.488 |
|
| 2010 |
Adesse D, Lisanti MP, Spray DC, Machado FS, Meirelles Mde N, Tanowitz HB, Garzoni LR. Trypanosoma cruzi infection results in the reduced expression of caveolin-3 in the heart. Cell Cycle (Georgetown, Tex.). 9: 1639-46. PMID 20372051 DOI: 10.4161/Cc.9.8.11509 |
0.369 |
|
| 2010 |
Zhou J, Wang C, Wang Z, Dampier W, Wu K, Casimiro MC, Chepelev I, Popov VM, Quong A, Tozeren A, Zhao K, Lisanti MP, Pestell RG. Attenuation of Forkhead signaling by the retinal determination factor DACH1 Proceedings of the National Academy of Sciences of the United States of America. 107: 6864-6869. PMID 20351289 DOI: 10.1073/Pnas.1002746107 |
0.497 |
|
| 2010 |
Gazzerro E, Assereto S, Bonetto A, Sotgia F, Scarfì S, Pistorio A, Bonuccelli G, Cilli M, Bruno C, Zara F, Lisanti MP, Minetti C. Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies. The American Journal of Pathology. 176: 1863-77. PMID 20304949 DOI: 10.2353/Ajpath.2010.090468 |
0.366 |
|
| 2010 |
Gu L, Dagvadorj A, Lutz J, Leiby B, Bonuccelli G, Lisanti MP, Addya S, Fortina P, Dasgupta A, Hyslop T, Bubendorf L, Nevalainen MT. Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth. The American Journal of Pathology. 176: 1959-72. PMID 20167868 DOI: 10.2353/Ajpath.2010.090653 |
0.325 |
|
| 2010 |
Yu Z, Baserga R, Chen L, Wang C, Lisanti MP, Pestell RG. microRNA, cell cycle, and human breast cancer. The American Journal of Pathology. 176: 1058-64. PMID 20075198 DOI: 10.2353/Ajpath.2010.090664 |
0.545 |
|
| 2010 |
Jiao X, Katiyar S, Willmarth NE, Liu M, Ma X, Flomenberg N, Lisanti MP, Pestell RG. c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion. The Journal of Biological Chemistry. 285: 8218-26. PMID 20053993 DOI: 10.1074/Jbc.M110.100792 |
0.546 |
|
| 2010 |
Xie L, Frank PG, Lisanti MP, Sowa G. Endothelial cells isolated from caveolin-2 knockout mice display higher proliferation rate and cell cycle progression relative to their wild-type counterparts. American Journal of Physiology. Cell Physiology. 298: C693-701. PMID 20007452 DOI: 10.1152/Ajpcell.00401.2009 |
0.658 |
|
| 2010 |
Park HC, Yasuda K, Ratliff B, Stoessel A, Sharkovska Y, Yamamoto I, Jasmin JF, Bachmann S, Lisanti MP, Chander P, Goligorsky MS. Postobstructive regeneration of kidney is derailed when surge in renal stem cells during course of unilateral ureteral obstruction is halted. American Journal of Physiology. Renal Physiology. 298: F357-64. PMID 19906947 DOI: 10.1152/Ajprenal.00542.2009 |
0.315 |
|
| 2010 |
Gazzerro E, Sotgia F, Bruno C, Lisanti MP, Minetti C. Caveolinopathies: From the biology of caveolin-3 to human diseases European Journal of Human Genetics. 18: 137-145. PMID 19584897 DOI: 10.1038/Ejhg.2009.103 |
0.319 |
|
| 2010 |
Vizio DD, Morello M, McNeish B, Schow P, Lisanti MP, Moses MA, Freeman MR. Abstract LB-242: Oncosomes: Large bioactive particles secreted by prostate cancer cells Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-242 |
0.345 |
|
| 2010 |
Rivadeneira D, Ertel A, Witkiewicz A, Mercier I, Lisanti M, Knudsen E. Abstract P4-01-04: The Impact of the Retinoblastoma Tumor Suppressor Pathway in Her2 Positive Breast Cancer Pathogenesis and Therapeutic Response Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P4-01-04 |
0.368 |
|
| 2009 |
Jasmin JF, Yang M, Iacovitti L, Lisanti MP. Genetic ablation of caveolin-1 increases neural stem cell proliferation in the subventricular zone (SVZ) of the adult mouse brain Cell Cycle. 8: 3978-3983. PMID 19923909 DOI: 10.4161/Cc.8.23.10206 |
0.322 |
|
| 2009 |
Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, Casimiro MC, Wang C, Fortina P, Addya S, Pestell RG, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle (Georgetown, Tex.). 8: 3984-4001. PMID 19923890 DOI: 10.4161/Cc.8.23.10238 |
0.721 |
|
| 2009 |
Nagajyothi F, Desruisseaux MS, Weiss LM, Chua S, Albanese C, Machado FS, Esper L, Lisanti MP, Teixeira MM, Scherer PE, Tanowitz HB. Chagas disease, adipose tissue and the metabolic syndrome. MemóRias Do Instituto Oswaldo Cruz. 104: 219-25. PMID 19753477 DOI: 10.1590/S0074-02762009000900028 |
0.305 |
|
| 2009 |
Zhou J, Zhang W, Liang B, Casimiro MC, Whitaker-Menezes D, Wang M, Lisanti MP, Lanza-Jacoby S, Pestell RG, Wang C. PPARgamma activation induces autophagy in breast cancer cells. The International Journal of Biochemistry & Cell Biology. 41: 2334-42. PMID 19563910 DOI: 10.1016/J.Biocel.2009.06.007 |
0.531 |
|
| 2009 |
Di Vizio D, Morello M, Sotgia F, Pestell RG, Freeman MR, Lisanti MP. An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation. Cell Cycle (Georgetown, Tex.). 8: 2420-4. PMID 19556867 DOI: 10.4161/Cc.8.15.9116 |
0.493 |
|
| 2009 |
Felicetti F, Parolini I, Bottero L, Fecchi K, Errico MC, Raggi C, Biffoni M, Spadaro F, Lisanti MP, Sargiacomo M, Carè A. Caveolin-1 tumor-promoting role in human melanoma. International Journal of Cancer. 125: 1514-22. PMID 19521982 DOI: 10.1002/Ijc.24451 |
0.423 |
|
| 2009 |
Witkiewicz AK, Dasgupta A, Nguyen KH, Liu C, Kovatich AJ, Schwartz GF, Pestell RG, Sotgia F, Rui H, Lisanti MP. Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer. Cancer Biology & Therapy. 8: 1071-9. PMID 19502809 DOI: 10.4161/Cbt.8.11.8874 |
0.486 |
|
| 2009 |
Nan F, Lü Q, Zhou J, Cheng L, Popov VM, Wei S, Kong B, Pestell RG, Lisanti MP, Jiang J, Wang C. Altered expression of DACH1 and cyclin D1 in endometrial cancer. Cancer Biology & Therapy. 8: 1534-9. PMID 19502783 DOI: 10.4161/Cbt.8.16.8963 |
0.507 |
|
| 2009 |
Witkiewicz AK, Casimiro MC, Dasgupta A, Mercier I, Wang C, Bonuccelli G, Jasmin JF, Frank PG, Pestell RG, Kleer CG, Sotgia F, Lisanti MP. Towards a new "stromal-based" classification system for human breast cancer prognosis and therapy. Cell Cycle (Georgetown, Tex.). 8: 1654-8. PMID 19448435 DOI: 10.4161/Cc.8.11.8544 |
0.695 |
|
| 2009 |
Brody JR, Costantino CL, Berger AC, Sato T, Lisanti MP, Yeo CJ, Emmons RV, Witkiewicz AK. Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival. Cell Cycle (Georgetown, Tex.). 8: 1930-4. PMID 19448397 DOI: 10.4161/Cc.8.12.8745 |
0.304 |
|
| 2009 |
Rodriguez OC, Lai EW, Vissapragada S, Cromelin C, Avetian M, Salinas P, Ramos H, Kallakury B, Casimiro M, Lisanti MP, Tanowitz HB, Pacak K, Glazer RI, Avantaggiati M, Albanese C. A reduction in Pten tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1. The American Journal of Pathology. 174: 2051-60. PMID 19443706 DOI: 10.2353/Ajpath.2009.080859 |
0.369 |
|
| 2009 |
Witkiewicz AK, Dasgupta A, Sotgia F, Mercier I, Pestell RG, Sabel M, Kleer CG, Brody JR, Lisanti MP. An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. The American Journal of Pathology. 174: 2023-34. PMID 19411448 DOI: 10.2353/Ajpath.2009.080873 |
0.513 |
|
| 2009 |
Bonuccelli G, Casimiro MC, Sotgia F, Wang C, Liu M, Katiyar S, Zhou J, Dew E, Capozza F, Daumer KM, Minetti C, Milliman JN, Alpy F, Rio MC, Tomasetto C, ... ... Lisanti MP, et al. Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature. The American Journal of Pathology. 174: 1650-62. PMID 19395651 DOI: 10.2353/Ajpath.2009.080648 |
0.728 |
|
| 2009 |
Mercier I, Bryant KG, Sotgia F, Bonuccelli G, Witkiewicz AK, Dasgupta A, Jasmin JF, Pestell RG, Lisanti MP. Using Caveolin-1 epithelial immunostaining patterns to stratify human breast cancer patients and predict the Caveolin-1 (P132L) mutation Cell Cycle. 8: 1396-1401. PMID 19342880 DOI: 10.4161/Cc.8.9.8307 |
0.486 |
|
| 2009 |
Mercier I, Casimiro MC, Zhou J, Wang C, Plymire C, Bryant KG, Daumer KM, Sotgia F, Bonuccelli G, Witkiewicz AK, Lin J, Tran TH, Milliman J, Frank PG, Jasmin JF, ... ... Lisanti MP, et al. Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions. The American Journal of Pathology. 174: 1172-90. PMID 19342371 DOI: 10.2353/Ajpath.2009.080882 |
0.709 |
|
| 2009 |
Mercier I, Jasmin JF, Pavlides S, Minetti C, Flomenberg N, Pestell RG, Frank PG, Sotgia F, Lisanti MP. Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders. Laboratory Investigation; a Journal of Technical Methods and Pathology. 89: 614-23. PMID 19333235 DOI: 10.1038/Labinvest.2009.23 |
0.688 |
|
| 2009 |
Sotgia F, Del Galdo F, Casimiro MC, Bonuccelli G, Mercier I, Whitaker-Menezes D, Daumer KM, Zhou J, Wang C, Katiyar S, Xu H, Bosco E, Quong AA, Aronow B, Witkiewicz AK, ... ... Lisanti MP, et al. Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts. The American Journal of Pathology. 174: 746-61. PMID 19234134 DOI: 10.2353/Ajpath.2009.080658 |
0.731 |
|
| 2009 |
Marmon S, Hinchey J, Oh P, Cammer M, de Almeida CJ, Gunther L, Raine CS, Lisanti MP. Caveolin-1 expression determines the route of neutrophil extravasation through skin microvasculature. The American Journal of Pathology. 174: 684-92. PMID 19164603 DOI: 10.2353/Ajpath.2009.080091 |
0.749 |
|
| 2009 |
Sotgia F, Casimiro MC, Bonuccelli G, Liu M, Whitaker-Menezes D, Er O, Daumer KM, Mercier I, Witkiewicz AK, Minetti C, Capozza F, Gormley M, Quong AA, Rui H, Frank PG, ... ... Lisanti MP, et al. Loss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formation. The American Journal of Pathology. 174: 613-29. PMID 19164602 DOI: 10.2353/Ajpath.2009.080653 |
0.739 |
|
| 2009 |
Marmon S, Cammer M, Raine CS, Lisanti MP. Transcellular migration of neutrophils is a quantitatively significant pathway across dermal microvascular endothelial cells. Experimental Dermatology. 18: 88-90. PMID 19040450 DOI: 10.1111/J.1600-0625.2008.00796.X |
0.742 |
|
| 2009 |
Marmon S, Hinchey J, Raine CS, Lisanti MP. Chemokine transport and leukocyte extravasation through dermal microvasculature in the absence of caveolae. Journal of Dermatological Science. 53: 225-8. PMID 19019633 DOI: 10.1016/J.Jdermsci.2008.09.006 |
0.692 |
|
| 2009 |
Frank PG, Pavlides S, Lisanti MP. Caveolae and transcytosis in endothelial cells: role in atherosclerosis. Cell and Tissue Research. 335: 41-7. PMID 18688651 DOI: 10.1007/S00441-008-0659-8 |
0.638 |
|
| 2009 |
Witkiewicz AK, Dasgupta A, Schwartz GF, Nguyen KH, Rui HR, Lisanti MP. Stromal Caveolin-1 Levels Predict Early Ductal Carcinoma In Situ Progression to Invasive Breast Carcinoma. Cancer Research. 69: 2136-2136. DOI: 10.1158/0008-5472.Sabcs-09-2136 |
0.324 |
|
| 2008 |
Lindsay J, Jiao X, Sakamaki T, Casimiro MC, Shirley LA, Tran TH, Ju X, Liu M, Li Z, Wang C, Katiyar S, Rao M, Allen KG, Glazer RI, Ge C, ... ... Lisanti MP, et al. ErbB2 induces Notch1 activity and function in breast cancer cells. Clinical and Translational Science. 1: 107-15. PMID 20443831 DOI: 10.1111/J.1752-8062.2008.00041.X |
0.463 |
|
| 2008 |
Nagajyothi F, Desruisseaux MS, Thiruvur N, Weiss LM, Braunstein VL, Albanese C, Teixeira MM, de Almeida CJ, Lisanti MP, Scherer PE, Tanowitz HB. Trypanosoma cruzi infection of cultured adipocytes results in an inflammatory phenotype. Obesity (Silver Spring, Md.). 16: 1992-7. PMID 19186325 DOI: 10.1038/Oby.2008.331 |
0.321 |
|
| 2008 |
Witkiewicz AK, Nguyen KH, Dasgupta A, Kennedy EP, Yeo CJ, Lisanti MP, Brody JR. Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma: implications for tumor progression and clinical outcome. Cell Cycle (Georgetown, Tex.). 7: 3021-5. PMID 18802406 DOI: 10.4161/Cc.7.19.6719 |
0.362 |
|
| 2008 |
Del Galdo F, Sotgia F, de Almeida CJ, Jasmin JF, Musick M, Lisanti MP, Jiménez SA. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis. Arthritis and Rheumatism. 58: 2854-65. PMID 18759267 DOI: 10.1002/Art.23791 |
0.321 |
|
| 2008 |
Augustus AS, Buchanan J, Gutman E, Rengo G, Pestell RG, Fortina P, Koch WJ, Bensadoun A, Abel ED, Lisanti MP. Hearts lacking caveolin-1 develop hypertrophy with normal cardiac substrate metabolism Cell Cycle. 7: 2509-2518. PMID 18719368 DOI: 10.4161/Cc.7.16.6421 |
0.495 |
|
| 2008 |
Frank PG, Lisanti MP. ICAM-1: role in inflammation and in the regulation of vascular permeability. American Journal of Physiology. Heart and Circulatory Physiology. 295: H926-H927. PMID 18689494 DOI: 10.1152/Ajpheart.00779.2008 |
0.617 |
|
| 2008 |
Assereto S, Mastrototaro M, Stringara S, Gazzerro E, Broda P, Nicchia GP, Svelto M, Bruno C, Nigro V, Lisanti MP, Frigeri A, Minetti C. Aquaporin-4 expression is severely reduced in human sarcoglycanopathies and dysferlinopathies. Cell Cycle (Georgetown, Tex.). 7: 2199-207. PMID 18641458 DOI: 10.4161/Cc.7.14.6272 |
0.327 |
|
| 2008 |
Di Vizio D, Adam RM, Kim J, Kim R, Sotgia F, Williams T, Demichelis F, Solomon KR, Loda M, Rubin MA, Lisanti MP, Freeman MR. Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase. Cell Cycle (Georgetown, Tex.). 7: 2257-67. PMID 18635971 DOI: 10.4161/Cc.7.14.6475 |
0.587 |
|
| 2008 |
Kim M, Wu X, Song I, Fu M, Chang SH, Lisanti MP, Pestell R. Selective cytotoxicity of synthesized procyanidin 3-O-galloylepicatechin- 4b, 8-3-O-galloylcatechin to human cancer cells Cell Cycle. 7: 1648-1657. PMID 18560275 DOI: 10.4161/Cc.7.11.5980 |
0.534 |
|
| 2008 |
Tamgüney G, Giles K, Glidden DV, Lessard P, Wille H, Tremblay P, Groth DF, Yehiely F, Korth C, Moore RC, Tatzelt J, Rubinstein E, Boucheix C, Yang X, Stanley P, ... Lisanti MP, et al. Genes contributing to prion pathogenesis. The Journal of General Virology. 89: 1777-88. PMID 18559949 DOI: 10.1099/Vir.0.2008/001255-0 |
0.313 |
|
| 2008 |
Augustus AS, Buchanan J, Addya S, Rengo G, Pestell RG, Fortina P, Koch WJ, Bensadoun A, Abel ED, Lisanti MP. Substrate uptake and metabolism are preserved in hypertrophic caveolin-3 knockout hearts American Journal of Physiology - Heart and Circulatory Physiology. 295: H657-H666. PMID 18552160 DOI: 10.1152/Ajpheart.00387.2008 |
0.535 |
|
| 2008 |
Frank PG, Pavlides S, Cheung MW, Daumer K, Lisanti MP. Role of caveolin-1 in the regulation of lipoprotein metabolism. American Journal of Physiology. Cell Physiology. 295: C242-8. PMID 18508910 DOI: 10.1152/Ajpcell.00185.2008 |
0.646 |
|
| 2008 |
Chen J, Capozza F, Wu A, Deangelis T, Sun H, Lisanti M, Baserga R. Regulation of insulin receptor substrate-1 expression levels by caveolin-1. Journal of Cellular Physiology. 217: 281-9. PMID 18506777 DOI: 10.1002/Jcp.21498 |
0.36 |
|
| 2008 |
Abdulghani J, Gu L, Dagvadorj A, Lutz J, Leiby B, Bonuccelli G, Lisanti MP, Zellweger T, Alanen K, Mirtti T, Visakorpi T, Bubendorf L, Nevalainen MT. Stat3 promotes metastatic progression of prostate cancer. The American Journal of Pathology. 172: 1717-28. PMID 18483213 DOI: 10.2353/Ajpath.2008.071054 |
0.315 |
|
| 2008 |
Mercier I, Vuolo M, Jasmin JF, Medina CM, Williams M, Mariadason JM, Qian H, Xue X, Pestell RG, Lisanti MP, Kitsis RN. ARC (apoptosis repressor with caspase recruitment domain) is a novel marker of human colon cancer Cell Cycle. 7: 1640-1647. PMID 18469522 DOI: 10.4161/Cc.7.11.5979 |
0.532 |
|
| 2008 |
Wu K, Katiyar S, Li A, Liu M, Ju X, Popov VM, Jiao X, Lisanti MP, Casola A, Pestell RG. Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8. Proceedings of the National Academy of Sciences of the United States of America. 105: 6924-9. PMID 18467491 DOI: 10.1073/Pnas.0802085105 |
0.548 |
|
| 2008 |
Mercier I, Casimiro MC, Wang C, Rosenberg AL, Quong J, Minkeu A, Allen KG, Danilo C, Sotgia F, Bonuccelli G, Jasmin JF, Xu H, Bosco E, Aronow B, Witkiewicz A, ... ... Lisanti MP, et al. Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapy Cancer Biology and Therapy. 7: 1212-1225. PMID 18458534 DOI: 10.4161/Cbt.7.8.6220 |
0.792 |
|
| 2008 |
Traverso M, Gazzerro E, Assereto S, Sotgia F, Biancheri R, Stringara S, Giberti L, Pedemonte M, Wang X, Scapolan S, Pasquini E, Donati MA, Zara F, Lisanti MP, Bruno C, et al. Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 275-83. PMID 18253147 DOI: 10.1038/Labinvest.3700713 |
0.335 |
|
| 2008 |
Rao M, Casimiro MC, Lisanti MP, D'Amico M, Wang C, Shirley LA, Leader JE, Liu M, Stallcup M, Engel DA, Murphy DJ, Pestell RG. Inhibition of cyclin D1 gene transcription by Brg-1. Cell Cycle (Georgetown, Tex.). 7: 647-55. PMID 18239461 DOI: 10.4161/Cc.7.5.5446 |
0.523 |
|
| 2008 |
Bouzahzah B, Yurchenko V, Nagajyothi F, Hulit J, Sadofsky M, Braunstein VL, Mukherjee S, Weiss H, Machado FS, Pestell RG, Lisanti MP, Tanowitz HB, Albanese C. Regulation of host cell cyclin D1 by Trypanosoma cruzi in myoblasts. Cell Cycle (Georgetown, Tex.). 7: 500-3. PMID 18239452 DOI: 10.4161/Cc.7.4.5327 |
0.461 |
|
| 2008 |
Jiao X, Katiyar S, Liu M, Mueller SC, Lisanti MP, Li A, Pestell TG, Wu K, Ju X, Li Z, Wagner EF, Takeya T, Wang C, Pestell RG. Disruption of c-Jun reduces cellular migration and invasion through inhibition of c-Src and hyperactivation of ROCK II kinase. Molecular Biology of the Cell. 19: 1378-90. PMID 18216279 DOI: 10.1091/Mbc.E07-08-0753 |
0.493 |
|
| 2008 |
Bianco C, Strizzi L, Mancino M, Watanabe K, Gonzales M, Hamada S, Raafat A, Sahlah L, Chang C, Sotgia F, Normanno N, Lisanti M, Salomon DS. Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells. The American Journal of Pathology. 172: 345-57. PMID 18202186 DOI: 10.2353/Ajpath.2008.070696 |
0.375 |
|
| 2008 |
Gioiosa L, Raggi C, Ricceri L, Jasmin JF, Frank PG, Capozza F, Lisanti MP, Alleva E, Sargiacomo M, Laviola G. Altered emotionality, spatial memory and cholinergic function in caveolin-1 knock-out mice. Behavioural Brain Research. 188: 255-62. PMID 18083242 DOI: 10.1016/J.Bbr.2007.11.002 |
0.625 |
|
| 2007 |
Di Vizio D, Sotgia F, Williams TM, Hassan GS, Capozza F, Frank PG, Pestell RG, Loda M, Freeman MR, Lisanti MP. Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progression. Cancer Biology & Therapy. 6: 1263-8. PMID 17786030 DOI: 10.4161/Cbt.6.8.4447 |
0.739 |
|
| 2007 |
Lai EW, Rodriguez OC, Aventian M, Cromelin C, Fricke ST, Martiniova L, Lubensky IA, Lisanti MP, Picard KL, Powers JF, Tischler AS, Pacak K, Albanese C. ErbB-2 induces bilateral adrenal pheochromocytoma formation in mice. Cell Cycle (Georgetown, Tex.). 6: 1946-50. PMID 17671425 DOI: 10.4161/Cc.6.15.4521 |
0.38 |
|
| 2007 |
Frank PG, Hassan GS, Rodriguez-Feo JA, Lisanti MP. Caveolae and caveolin-1: novel potential targets for the treatment of cardiovascular disease. Current Pharmaceutical Design. 13: 1761-9. PMID 17584106 DOI: 10.2174/138161207780831202 |
0.669 |
|
| 2007 |
Bonuccelli G, Sotgia F, Capozza F, Gazzerro E, Minetti C, Lisanti MP. Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice. Cell Cycle (Georgetown, Tex.). 6: 1242-8. PMID 17495527 DOI: 10.4161/Cc.6.10.4182 |
0.336 |
|
| 2007 |
Ju X, Katiyar S, Wang C, Liu M, Jiao X, Li S, Zhou J, Turner J, Lisanti MP, Russell RG, Mueller SC, Ojeifo J, Chen WS, Hay N, Pestell RG. Akt1 governs breast cancer progression in vivo. Proceedings of the National Academy of Sciences of the United States of America. 104: 7438-43. PMID 17460049 DOI: 10.1073/Pnas.0605874104 |
0.725 |
|
| 2007 |
Hulit J, Suyama K, Chung S, Keren R, Agiostratidou G, Shan W, Dong X, Williams TM, Lisanti MP, Knudsen K, Hazan RB. N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation. Cancer Research. 67: 3106-16. PMID 17409417 DOI: 10.1158/0008-5472.Can-06-3401 |
0.557 |
|
| 2007 |
Medina FA, Cohen AW, de Almeida CJ, Nagajyothi F, Braunstein VL, Teixeira MM, Tanowitz HB, Lisanti MP. Immune dysfunction in caveolin-1 null mice following infection with Trypanosoma cruzi (Tulahuen strain). Microbes and Infection / Institut Pasteur. 9: 325-33. PMID 17317261 DOI: 10.1016/J.Micinf.2006.12.011 |
0.663 |
|
| 2007 |
Frank PG, Lisanti MP. Caveolin-1 and liver regeneration: role in proliferation and lipogenesis. Cell Cycle (Georgetown, Tex.). 6: 115-6. PMID 17314510 DOI: 10.4161/Cc.6.2.3722 |
0.614 |
|
| 2007 |
Jasmin JF, Malhotra S, Singh Dhallu M, Mercier I, Rosenbaum DM, Lisanti MP. Caveolin-1 deficiency increases cerebral ischemic injury. Circulation Research. 100: 721-9. PMID 17293479 DOI: 10.1161/01.Res.0000260180.42709.29 |
0.304 |
|
| 2007 |
Fang K, Fu W, Beardsley AR, Sun X, Lisanti MP, Liu J. Overexpression of caveolin-1 inhibits endothelial cell proliferation by arresting the cell cycle at G0/G1 phase. Cell Cycle (Georgetown, Tex.). 6: 199-204. PMID 17245131 DOI: 10.4161/Cc.6.2.3740 |
0.384 |
|
| 2007 |
Schubert W, Sotgia F, Cohen AW, Capozza F, Bonuccelli G, Bruno C, Minetti C, Bonilla E, Dimauro S, Lisanti MP. Caveolin-1(-/-)- and caveolin-2(-/-)-deficient mice both display numerous skeletal muscle abnormalities, with tubular aggregate formation. The American Journal of Pathology. 170: 316-33. PMID 17200204 DOI: 10.2353/Ajpath.2007.060687 |
0.716 |
|
| 2007 |
Wu K, Liu M, Li A, Donninger H, Rao M, Jiao X, Lisanti MP, Cvekl A, Birrer M, Pestell RG. Cell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growth. Molecular Biology of the Cell. 18: 755-67. PMID 17182846 DOI: 10.1091/Mbc.E06-09-0793 |
0.477 |
|
| 2007 |
Katiyar S, Jiao X, Wagner E, Lisanti MP, Pestell RG. Somatic excision demonstrates that c-Jun induces cellular migration and invasion through induction of stem cell factor Molecular and Cellular Biology. 27: 1356-1369. PMID 17145782 DOI: 10.1128/Mcb.01061-06 |
0.521 |
|
| 2006 |
Frank PG, Lisanti MP. Zebrafish as a novel model system to study the function of caveolae and caveolin-1 in organismal biology. The American Journal of Pathology. 169: 1910-2. PMID 17148656 DOI: 10.2353/Ajpath.2006.060923 |
0.63 |
|
| 2006 |
Sotgia F, Rui H, Bonuccelli G, Mercier I, Pestell RG, Lisanti MP. Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers. Cancer Research. 66: 10647-51. PMID 17108100 DOI: 10.1158/0008-5472.Can-06-2805 |
0.578 |
|
| 2006 |
Bouzahzah B, Nagajyothi F, Desruisseaux MS, Krishnamachary M, Factor SM, Cohen AW, Lisanti MP, Petkova SB, Pestell RG, Wittner M, Mukherjee S, Weiss LM, Jelicks LA, Albanese C, Tanowitz HB. Cell cycle regulatory proteins in the liver in murine Trypanosoma cruzi infection. Cell Cycle (Georgetown, Tex.). 5: 2396-400. PMID 17102609 DOI: 10.4161/Cc.5.20.3380 |
0.497 |
|
| 2006 |
Williams TM, Sotgia F, Lee H, Hassan G, Di Vizio D, Bonuccelli G, Capozza F, Mercier I, Rui H, Pestell RG, Lisanti MP. Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells. The American Journal of Pathology. 169: 1784-801. PMID 17071600 DOI: 10.2353/Ajpath.2006.060590 |
0.751 |
|
| 2006 |
Li Z, Jiao X, Wang C, Ju X, Lu Y, Yuan L, Lisanti MP, Katiyar S, Pestell RG. Cyclin D1 induction of cellular migration requires p27(KIP1). Cancer Research. 66: 9986-94. PMID 17047061 DOI: 10.1158/0008-5472.Can-06-1596 |
0.49 |
|
| 2006 |
Medina FA, de Almeida CJ, Dew E, Li J, Bonuccelli G, Williams TM, Cohen AW, Pestell RG, Frank PG, Tanowitz HB, Lisanti MP. Caveolin-1-deficient mice show defects in innate immunity and inflammatory immune response during Salmonella enterica serovar Typhimurium infection. Infection and Immunity. 74: 6665-74. PMID 16982844 DOI: 10.1128/Iai.00949-06 |
0.788 |
|
| 2006 |
Wu K, Li A, Rao M, Liu M, Dailey V, Yang Y, Di Vizio D, Wang C, Lisanti MP, Sauter G, Russell RG, Cvekl A, Pestell RG. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth. Molecular and Cellular Biology. 26: 7116-29. PMID 16980615 DOI: 10.1128/Mcb.00268-06 |
0.554 |
|
| 2006 |
Hnasko R, Carter JM, Medina F, Frank PG, Lisanti MP. PV-1 labels trans-cellular openings in mouse endothelial cells and is negatively regulated by VEGF. Cell Cycle (Georgetown, Tex.). 5: 2021-8. PMID 16969078 DOI: 10.4161/Cc.5.17.3217 |
0.777 |
|
| 2006 |
Hnasko R, Frank PG, Ben-Jonathan N, Lisanti MP. PV-1 is negatively regulated by VEGF in the lung of caveolin-1, but not caveolin-2, null mice. Cell Cycle (Georgetown, Tex.). 5: 2012-20. PMID 16969073 DOI: 10.4161/Cc.5.17.3216 |
0.64 |
|
| 2006 |
Hulit J, Lee RJ, Li Z, Wang C, Katiyar S, Yang J, Quong AA, Wu K, Albanese C, Russell R, Di Vizio D, Koff A, Thummala S, Zhang H, Harrell J, ... ... Lisanti MP, et al. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling. Cancer Research. 66: 8529-41. PMID 16951165 DOI: 10.1158/0008-5472.Can-06-0149 |
0.521 |
|
| 2006 |
Medina FA, Williams TM, Sotgia F, Tanowitz HB, Lisanti MP. A novel role for caveolin-1 in B lymphocyte function and the development of thymus-independent immune responses. Cell Cycle (Georgetown, Tex.). 5: 1865-71. PMID 16929183 DOI: 10.4161/Cc.5.16.3132 |
0.702 |
|
| 2006 |
Li T, Sotgia F, Vuolo MA, Li M, Yang WC, Pestell RG, Sparano JA, Lisanti MP. Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status. The American Journal of Pathology. 168: 1998-2013. PMID 16723714 DOI: 10.2353/Ajpath.2006.051089 |
0.519 |
|
| 2006 |
Frank PG, Lisanti MP. Role of caveolin-1 in the regulation of the vascular shear stress response. The Journal of Clinical Investigation. 116: 1222-5. PMID 16670766 DOI: 10.1172/Jci28509 |
0.644 |
|
| 2006 |
Jasmin JF, Mercier I, Sotgia F, Lisanti MP. SOCS proteins and caveolin-1 as negative regulators of endocrine signaling Trends in Endocrinology and Metabolism. 17: 150-158. PMID 16616514 DOI: 10.1016/J.Tem.2006.03.007 |
0.328 |
|
| 2006 |
Frank PG, Cheung MW, Pavlides S, Llaverias G, Park DS, Lisanti MP. Caveolin-1 and regulation of cellular cholesterol homeostasis. American Journal of Physiology. Heart and Circulatory Physiology. 291: H677-86. PMID 16603689 DOI: 10.1152/Ajpheart.01092.2005 |
0.634 |
|
| 2006 |
Frank PG, Lisanti MP. Defining lipid raft structure and function with proximity imaging. American Journal of Physiology. Heart and Circulatory Physiology. 290: H2165-6. PMID 16428346 DOI: 10.1152/Ajpheart.00041.2006 |
0.598 |
|
| 2006 |
Sotgia F, Schubert W, Pestell RG, Lisanti MP. Genetic ablation of caveolin-1 in mammary epithelial cells increases milk production and hyper-activates STAT5a signaling Cancer Biology and Therapy. 5: 292-297. PMID 16418573 DOI: 10.4161/Cbt.5.3.2390 |
0.791 |
|
| 2006 |
Hassan GS, Williams TM, Frank PG, Lisanti MP. Caveolin-1-deficient aortic smooth muscle cells show cell autonomous abnormalities in proliferation, migration, and endothelin-based signal transduction. American Journal of Physiology. Heart and Circulatory Physiology. 290: H2393-401. PMID 16415072 DOI: 10.1152/Ajpheart.01161.2005 |
0.709 |
|
| 2006 |
Khan EM, Heidinger JM, Levy M, Lisanti MP, Ravid T, Goldkorn T. Epidermal growth factor receptor exposed to oxidative stress undergoes Src- and caveolin-1-dependent perinuclear trafficking. The Journal of Biological Chemistry. 281: 14486-93. PMID 16407214 DOI: 10.1074/Jbc.M509332200 |
0.309 |
|
| 2006 |
Sotgia F, Williams TM, Schubert W, Medina F, Minetti C, Pestell RG, Lisanti MP. Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness. The American Journal of Pathology. 168: 292-309. PMID 16400031 DOI: 10.2353/Ajpath.2006.050429 |
0.807 |
|
| 2006 |
Lee H, Xie L, Luo Y, Lee SY, Lawrence DS, Wang XB, Sotgia F, Lisanti MP, Zhang ZY. Identification of phosphocaveolin-1 as a novel protein tyrosine phosphatase 1B substrate. Biochemistry. 45: 234-40. PMID 16388599 DOI: 10.1021/Bi051560J |
0.561 |
|
| 2006 |
Hassan GS, Mukherjee S, Nagajyothi F, Weiss LM, Petkova SB, de Almeida CJ, Huang H, Desruisseaux MS, Bouzahzah B, Pestell RG, Albanese C, Christ GJ, Lisanti MP, Tanowitz HB. Trypanosoma cruzi infection induces proliferation of vascular smooth muscle cells. Infection and Immunity. 74: 152-9. PMID 16368968 DOI: 10.1128/Iai.74.1.152-159.2006 |
0.522 |
|
| 2006 |
Rodriguez O, Fricke S, Chien C, Dettin L, VanMeter J, Shapiro E, Dai HN, Casimiro M, Ileva L, Dagata J, Johnson MD, Lisanti MP, Koretsky A, Albanese C. Contrast-enhanced in vivo imaging of breast and prostate cancer cells by MRI. Cell Cycle (Georgetown, Tex.). 5: 113-9. PMID 16340310 DOI: 10.4161/Cc.5.1.2295 |
0.34 |
|
| 2006 |
Nagajyothi F, Desruisseaux M, Bouzahzah B, Weiss LM, Andrade Ddos S, Factor SM, Scherer PE, Albanese C, Lisanti MP, Tanowitz HB. Cyclin and caveolin expression in an acute model of murine Chagasic myocarditis. Cell Cycle (Georgetown, Tex.). 5: 107-12. PMID 16319533 DOI: 10.4161/Cc.5.1.2284 |
0.364 |
|
| 2005 |
Li J, Hassan GS, Williams TM, Minetti C, Pestell RG, Tanowitz HB, Frank PG, Sotgia F, Lisanti MP. Loss of caveolin-1 causes the hyper-proliferation of intestinal crypt stem cells, with increased sensitivity to whole body gamma-radiation. Cell Cycle (Georgetown, Tex.). 4: 1817-25. PMID 16294037 DOI: 10.4161/Cc.4.12.2199 |
0.745 |
|
| 2005 |
Sotgia F, Williams TM, Cohen AW, Minetti C, Pestell RG, Lisanti MP. Caveolin-1-deficient mice have an increased mammary stem cell population with upregulation of Wnt/beta-catenin signaling. Cell Cycle (Georgetown, Tex.). 4: 1808-16. PMID 16294019 DOI: 10.4161/Cc.4.12.2198 |
0.639 |
|
| 2005 |
Li J, Scherl A, Medina F, Frank PG, Kitsis RN, Tanowitz HB, Sotgia F, Lisanti MP. Impaired phagocytosis in caveolin-1 deficient macrophages. Cell Cycle (Georgetown, Tex.). 4: 1599-607. PMID 16205123 DOI: 10.4161/Cc.4.11.2117 |
0.788 |
|
| 2005 |
Fine SW, Lisanti MP, Argani P, Li M. Caveolin-3 is a sensitive and specific marker for rhabdomyosarcoma Applied Immunohistochemistry and Molecular Morphology. 13: 231-236. PMID 16082247 DOI: 10.1097/00129039-200509000-00003 |
0.386 |
|
| 2005 |
Wang C, Fan S, Li Z, Fu M, Rao M, Ma Y, Lisanti MP, Albanese C, Katzenellenbogen BS, Kushner PJ, Weber B, Rosen EM, Pestell RG. Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity. Cancer Research. 65: 6557-67. PMID 16061635 DOI: 10.1158/0008-5472.Can-05-0486 |
0.523 |
|
| 2005 |
Fu M, Wang C, Rao M, Wu X, Bouras T, Zhang X, Li Z, Jiao X, Yang J, Li A, Perkins ND, Thimmapaya B, Kung AL, Munoz A, Giordano A, ... Lisanti MP, et al. Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism. The Journal of Biological Chemistry. 280: 29728-42. PMID 15951563 DOI: 10.1074/Jbc.M503188200 |
0.49 |
|
| 2005 |
Combs TP, Nagajyothi, Mukherjee S, de Almeida CJ, Jelicks LA, Schubert W, Lin Y, Jayabalan DS, Zhao D, Braunstein VL, Landskroner-Eiger S, Cordero A, Factor SM, Weiss LM, Lisanti MP, et al. The adipocyte as an important target cell for Trypanosoma cruzi infection. The Journal of Biological Chemistry. 280: 24085-94. PMID 15843370 DOI: 10.1074/Jbc.M412802200 |
0.703 |
|
| 2005 |
Iyengar P, Espina V, Williams TW, Lin Y, Berry D, Jelicks LA, Lee H, Temple K, Graves R, Pollard J, Chopra N, Russell RG, Sasisekharan R, Trock BJ, Lippman M, ... ... Lisanti MP, et al. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. The Journal of Clinical Investigation. 115: 1163-76. PMID 15841211 DOI: 10.1172/Jci23424 |
0.685 |
|
| 2005 |
Williams TM, Hassan GS, Li J, Cohen AW, Medina F, Frank PG, Pestell RG, Di Vizio D, Loda M, Lisanti MP. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. The Journal of Biological Chemistry. 280: 25134-45. PMID 15802273 DOI: 10.1074/Jbc.M501186200 |
0.796 |
|
| 2005 |
Roy S, Hyogo H, Yadav SK, Wu MK, Jelicks LA, Locker JD, Frank PG, Lisanti MP, Silver DL, Cohen DE. A biphasic response of hepatobiliary cholesterol metabolism to dietary fat at the onset of obesity in the mouse. Hepatology (Baltimore, Md.). 41: 887-95. PMID 15793852 DOI: 10.1002/Hep.20643 |
0.591 |
|
| 2005 |
Hotchkiss KA, Basile CM, Spring SC, Bonuccelli G, Lisanti MP, Terman BI. TEM8 expression stimulates endothelial cell adhesion and migration by regulating cell-matrix interactions on collagen. Experimental Cell Research. 305: 133-44. PMID 15777794 DOI: 10.1016/J.Yexcr.2004.12.025 |
0.392 |
|
| 2005 |
Cohen AW, Schubert W, Brasaemle DL, Scherer PE, Lisanti MP. Caveolin-1 expression is essential for proper nonshivering thermogenesis in brown adipose tissue. Diabetes. 54: 679-86. PMID 15734843 DOI: 10.2337/Diabetes.54.3.679 |
0.718 |
|
| 2005 |
De Souza AP, Cohen AW, Park DS, Woodman SE, Tang B, Gutstein DE, Factor SM, Tanowitz HB, Lisanti MP, Jelicks LA. MR imaging of caveolin gene-specific alterations in right ventricular wall thickness. Magnetic Resonance Imaging. 23: 61-8. PMID 15733789 DOI: 10.1016/J.Mri.2004.11.011 |
0.571 |
|
| 2005 |
Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. American Journal of Physiology. Cell Physiology. 288: C494-506. PMID 15692148 DOI: 10.1152/Ajpcell.00458.2004 |
0.592 |
|
| 2005 |
Capozza F, Combs TP, Cohen AW, Cho YR, Park SY, Schubert W, Williams TM, Brasaemle DL, Jelicks LA, Scherer PE, Kim JK, Lisanti MP. Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. American Journal of Physiology. Cell Physiology. 288: C1317-31. PMID 15689413 DOI: 10.1152/Ajpcell.00489.2004 |
0.742 |
|
| 2005 |
Bonuccelli G, Sotgia F, Frank PG, Williams TM, de Almeida CJ, Tanowitz HB, Scherer PE, Hotchkiss KA, Terman BI, Rollman B, Alileche A, Brojatsch J, Lisanti MP. ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection. American Journal of Physiology. Cell Physiology. 288: C1402-10. PMID 15689409 DOI: 10.1152/Ajpcell.00582.2004 |
0.723 |
|
| 2005 |
Capozza F, Cohen AW, Cheung MW, Sotgia F, Schubert W, Battista M, Lee H, Frank PG, Lisanti MP. Muscle-specific interaction of caveolin isoforms: differential complex formation between caveolins in fibroblastic vs. muscle cells. American Journal of Physiology. Cell Physiology. 288: C677-91. PMID 15548572 DOI: 10.1152/Ajpcell.00232.2004 |
0.801 |
|
| 2005 |
Jasmin JF, Frank PG, Lisanti MP. Chapter 11 Caveolin Proteins in Cardiopulmonary Disease and Lung Cancers Advances in Molecular and Cell Biology. 36: 211-233. DOI: 10.1016/S1569-2558(05)36011-5 |
0.638 |
|
| 2005 |
Hassan GS, Lisanti MP, Frank PG. Chapter 10 Caveolae and Caveolins in the Vascular System: Functional Roles in Endothelia, Macrophages, and Smooth Muscle Cells Advances in Molecular and Cell Biology. 36: 187-209. DOI: 10.1016/S1569-2558(05)36010-3 |
0.625 |
|
| 2004 |
Williams TM, Lisanti MP. The Caveolin genes: from cell biology to medicine. Annals of Medicine. 36: 584-95. PMID 15768830 DOI: 10.1080/07853890410018899 |
0.589 |
|
| 2004 |
Bouras T, Lisanti MP, Pestell RG. Caveolin-1 in breast cancer Cancer Biology and Therapy. 3: 931-941. PMID 15539932 DOI: 10.4161/Cbt.3.10.1147 |
0.568 |
|
| 2004 |
Wang XB, Lee H, Capozza F, Marmon S, Sotgia F, Brooks JW, Campos-Gonzalez R, Lisanti MP. Tyrosine phosphorylation of caveolin-2 at residue 27: differences in the spatial and temporal behavior of phospho-Cav-2 (pY19 and pY27). Biochemistry. 43: 13694-706. PMID 15504032 DOI: 10.1021/Bi049295+ |
0.776 |
|
| 2004 |
Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins in health and disease. Physiological Reviews. 84: 1341-79. PMID 15383654 DOI: 10.1152/Physrev.00046.2003 |
0.729 |
|
| 2004 |
Frank PG, Lisanti MP. Caveolin-1 and caveolae in atherosclerosis: differential roles in fatty streak formation and neointimal hyperplasia. Current Opinion in Lipidology. 15: 523-9. PMID 15361787 DOI: 10.1097/00041433-200410000-00005 |
0.678 |
|
| 2004 |
Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG, Lisanti MP. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. The Journal of Biological Chemistry. 279: 51630-46. PMID 15355971 DOI: 10.1074/Jbc.M409214200 |
0.802 |
|
| 2004 |
Mukherjee S, Huang H, Petkova SB, Albanese C, Pestell RG, Braunstein VL, Christ GJ, Wittner M, Lisanti MP, Berman JW, Weiss LM, Tanowitz HB. Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells. Infection and Immunity. 72: 5274-82. PMID 15322023 DOI: 10.1128/Iai.72.9.5274-5282.2004 |
0.51 |
|
| 2004 |
Subramanian V, Rothenberg A, Gomez C, Cohen AW, Garcia A, Bhattacharyya S, Shapiro L, Dolios G, Wang R, Lisanti MP, Brasaemle DL. Perilipin A mediates the reversible binding of CGI-58 to lipid droplets in 3T3-L1 adipocytes. The Journal of Biological Chemistry. 279: 42062-71. PMID 15292255 DOI: 10.1074/Jbc.M407462200 |
0.317 |
|
| 2004 |
Hassan GS, Jasmin JF, Schubert W, Frank PG, Lisanti MP. Caveolin-1 deficiency stimulates neointima formation during vascular injury. Biochemistry. 43: 8312-21. PMID 15222744 DOI: 10.1021/Bi049609T |
0.801 |
|
| 2004 |
Chu C, Alapat D, Wen X, Timo K, Burstein D, Lisanti M, Shears S, Kohtz DS. Ectopic expression of murine diphosphoinositol polyphosphate phosphohydrolase 1 attenuates signaling through the ERK1/2 pathway. Cellular Signalling. 16: 1045-59. PMID 15212765 DOI: 10.1016/J.Cellsig.2004.02.009 |
0.332 |
|
| 2004 |
Cohen AW, Razani B, Schubert W, Williams TM, Wang XB, Iyengar P, Brasaemle DL, Scherer PE, Lisanti MP. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes. 53: 1261-70. PMID 15111495 DOI: 10.2337/Diabetes.53.5.1261 |
0.806 |
|
| 2004 |
Williams TM, Lee H, Cheung MW, Cohen AW, Razani B, Iyengar P, Scherer PE, Pestell RG, Lisanti MP. Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/CAV-1 in mammary epithelial cell hyperplasia. The Journal of Biological Chemistry. 279: 24745-56. PMID 15044451 DOI: 10.1074/Jbc.M402064200 |
0.8 |
|
| 2004 |
Williams TM, Lisanti MP. The caveolin proteins. Genome Biology. 5: 214. PMID 15003112 DOI: 10.1186/Gb-2004-5-3-214 |
0.573 |
|
| 2004 |
Woodman SE, Sotgia F, Galbiati F, Minetti C, Lisanti MP. Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. Neurology. 62: 538-43. PMID 14981167 DOI: 10.1212/Wnl.62.4.538 |
0.598 |
|
| 2004 |
Woodman SE, Cheung MW, Tarr M, North AC, Schubert W, Lagaud G, Marks CB, Russell RG, Hassan GS, Factor SM, Christ GJ, Lisanti MP. Urogenital alterations in aged male caveolin-1 knockout mice. The Journal of Urology. 171: 950-7. PMID 14713860 DOI: 10.1097/01.Ju.0000105102.72295.B8 |
0.781 |
|
| 2004 |
Frank PG, Lee H, Park DS, Tandon NN, Scherer PE, Lisanti MP. Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 24: 98-105. PMID 14563650 DOI: 10.1161/01.Atv.0000101182.89118.E5 |
0.739 |
|
| 2003 |
Hnasko R, Lisanti MP. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease Mol Interv. 3: 445-464. PMID 14993453 DOI: 10.1124/Mi.3.8.445 |
0.428 |
|
| 2003 |
Park DS, Cohen AW, Frank PG, Razani B, Lee H, Williams TM, Chandra M, Shirani J, De Souza AP, Tang B, Jelicks LA, Factor SM, Weiss LM, Tanowitz HB, Lisanti MP. Caveolin-1 null (-/-) mice show dramatic reductions in life span. Biochemistry. 42: 15124-31. PMID 14690422 DOI: 10.1021/Bi0356348 |
0.799 |
|
| 2003 |
Sotgia F, Bonuccelli G, Minetti C, Woodman SE, Capozza F, Kemp RG, Scherer PE, Lisanti MP. Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases. The American Journal of Pathology. 163: 2619-34. PMID 14633633 DOI: 10.1016/S0002-9440(10)63616-4 |
0.605 |
|
| 2003 |
Cohen AW, Combs TP, Scherer PE, Lisanti MP. Role of caveolin and caveolae in insulin signaling and diabetes. American Journal of Physiology. Endocrinology and Metabolism. 285: E1151-60. PMID 14607781 DOI: 10.1152/Ajpendo.00324.2003 |
0.306 |
|
| 2003 |
Wu K, Yang Y, Wang C, Davoli MA, D'Amico M, Li A, Cveklova K, Kozmik Z, Lisanti MP, Russell RG, Cvekl A, Pestell RG. DACH1 inhibits transforming growth factor-beta signaling through binding Smad4. The Journal of Biological Chemistry. 278: 51673-84. PMID 14525983 DOI: 10.1074/Jbc.M310021200 |
0.498 |
|
| 2003 |
Iyengar P, Combs TP, Shah SJ, Gouon-Evans V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C, Lisanti MP, Pestell RG, Scherer PE. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene. 22: 6408-23. PMID 14508521 DOI: 10.1038/Sj.Onc.1206737 |
0.571 |
|
| 2003 |
Bonuccelli G, Sotgia F, Schubert W, Park DS, Frank PG, Woodman SE, Insabato L, Cammer M, Minetti C, Lisanti MP. Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins. The American Journal of Pathology. 163: 1663-75. PMID 14507673 DOI: 10.1016/S0002-9440(10)63523-7 |
0.794 |
|
| 2003 |
Aravamudan B, Volonte D, Ramani R, Gursoy E, Lisanti MP, London B, Galbiati F. Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype. Human Molecular Genetics. 12: 2777-88. PMID 12966035 DOI: 10.1093/Hmg/Ddg313 |
0.354 |
|
| 2003 |
Sotgia F, Woodman SE, Bonuccelli G, Capozza F, Minetti C, Scherer PE, Lisanti MP. Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease. American Journal of Physiology. Cell Physiology. 285: C1150-60. PMID 12839838 DOI: 10.1152/Ajpcell.00166.2003 |
0.593 |
|
| 2003 |
Schubert W, Yang XY, Yang TT, Factor SM, Lisanti MP, Molkentin JD, Rincon M, Chow CW. Requirement of transcription factor NFAT in developing atrial myocardium. The Journal of Cell Biology. 161: 861-74. PMID 12796475 DOI: 10.1083/Jcb.200301058 |
0.715 |
|
| 2003 |
Sotgia F, Bonuccelli G, Bedford M, Brancaccio A, Mayer U, Wilson MT, Campos-Gonzalez R, Brooks JW, Sudol M, Lisanti MP. Localization of phospho-beta-dystroglycan (pY892) to an intracellular vesicular compartment in cultured cells and skeletal muscle fibers in vivo. Biochemistry. 42: 7110-23. PMID 12795607 DOI: 10.1021/Bi0271289 |
0.312 |
|
| 2003 |
Woodman SE, Ashton AW, Schubert W, Lee H, Williams TM, Medina FA, Wyckoff JB, Combs TP, Lisanti MP. Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli. The American Journal of Pathology. 162: 2059-68. PMID 12759260 DOI: 10.1016/S0002-9440(10)64337-4 |
0.803 |
|
| 2003 |
Capozza F, Williams TM, Schubert W, McClain S, Bouzahzah B, Sotgia F, Lisanti MP. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. The American Journal of Pathology. 162: 2029-39. PMID 12759258 DOI: 10.1016/S0002-9440(10)64335-0 |
0.783 |
|
| 2003 |
Huang H, Petkova SB, Cohen AW, Bouzahzah B, Chan J, Zhou JN, Factor SM, Weiss LM, Krishnamachary M, Mukherjee S, Wittner M, Kitsis RN, Pestell RG, Lisanti MP, Albanese C, et al. Activation of transcription factors AP-1 and NF-kappa B in murine Chagasic myocarditis. Infection and Immunity. 71: 2859-67. PMID 12704159 DOI: 10.1128/Iai.71.5.2859-2867.2003 |
0.527 |
|
| 2003 |
Frank PG, Woodman SE, Park DS, Lisanti MP. Caveolin, caveolae, and endothelial cell function. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 1161-8. PMID 12689915 DOI: 10.1161/01.Atv.0000070546.16946.3A |
0.761 |
|
| 2003 |
Cohen AW, Razani B, Wang XB, Combs TP, Williams TM, Scherer PE, Lisanti MP. Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. American Journal of Physiology. Cell Physiology. 285: C222-35. PMID 12660144 DOI: 10.1152/Ajpcell.00006.2003 |
0.664 |
|
| 2003 |
Williams TM, Cheung MW, Park DS, Razani B, Cohen AW, Muller WJ, Di Vizio D, Chopra NG, Pestell RG, Lisanti MP. Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice. Molecular Biology of the Cell. 14: 1027-42. PMID 12631721 DOI: 10.1091/Mbc.E02-08-0503 |
0.746 |
|
| 2003 |
Cohen AW, Park DS, Woodman SE, Williams TM, Chandra M, Shirani J, Pereira de Souza A, Kitsis RN, Russell RG, Weiss LM, Tang B, Jelicks LA, Factor SM, Shtutin V, Tanowitz HB, ... Lisanti MP, et al. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. American Journal of Physiology. Cell Physiology. 284: C457-74. PMID 12388077 DOI: 10.1152/Ajpcell.00380.2002 |
0.673 |
|
| 2002 |
Fu M, Wang C, Wang J, Zafonte BT, Lisanti MP, Pestell RG. Acetylation in hormone signaling and the cell cycle. Cytokine & Growth Factor Reviews. 13: 259-76. PMID 12486878 DOI: 10.1016/S1359-6101(02)00003-5 |
0.511 |
|
| 2002 |
Sörensson J, Fierlbeck W, Heider T, Schwarz K, Park DS, Mundel P, Lisanti M, Ballermann BJ. Glomerular endothelial fenestrae in vivo are not formed from caveolae. Journal of the American Society of Nephrology : Jasn. 13: 2639-47. PMID 12397033 DOI: 10.1097/01.Asn.0000033277.32822.23 |
0.385 |
|
| 2002 |
Park DS, Lee H, Frank PG, Razani B, Nguyen AV, Parlow AF, Russell RG, Hulit J, Pestell RG, Lisanti MP. Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade. Molecular Biology of the Cell. 13: 3416-30. PMID 12388746 DOI: 10.1091/Mbc.02-05-0071 |
0.809 |
|
| 2002 |
Lee H, Park DS, Razani B, Russell RG, Pestell RG, Lisanti MP. Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia. The American Journal of Pathology. 161: 1357-69. PMID 12368209 DOI: 10.1016/S0002-9440(10)64412-4 |
0.776 |
|
| 2002 |
Frank PG, Marcel YL, Connelly MA, Lublin DM, Franklin V, Williams DL, Lisanti MP. Stabilization of caveolin-1 by cellular cholesterol and scavenger receptor class B type I. Biochemistry. 41: 11931-40. PMID 12269838 DOI: 10.1021/Bi0257078 |
0.728 |
|
| 2002 |
Razani B, Woodman SE, Lisanti MP. Caveolae: from cell biology to animal physiology. Pharmacological Reviews. 54: 431-67. PMID 12223531 DOI: 10.1124/Pr.54.3.431 |
0.737 |
|
| 2002 |
Schubert W, Frank PG, Woodman SE, Hyogo H, Cohen DE, Chow CW, Lisanti MP. Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice. The Journal of Biological Chemistry. 277: 40091-8. PMID 12167625 DOI: 10.1074/Jbc.M205948200 |
0.808 |
|
| 2002 |
Woodman SE, Park DS, Cohen AW, Cheung MW, Chandra M, Shirani J, Tang B, Jelicks LA, Kitsis RN, Christ GJ, Factor SM, Tanowitz HB, Lisanti MP. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. The Journal of Biological Chemistry. 277: 38988-97. PMID 12138167 DOI: 10.1074/Jbc.M205511200 |
0.633 |
|
| 2002 |
Volonte D, Zhang K, Lisanti MP, Galbiati F. Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts: Stress-induced premature senescence upregulates the expression of endogenous caveolin-1 Molecular Biology of the Cell. 13: 2502-2517. PMID 12134086 DOI: 10.1091/Mbc.01-11-0529 |
0.421 |
|
| 2002 |
Lee H, Park DS, Wang XB, Scherer PE, Schwartz PE, Lisanti MP. Src-induced phosphorylation of caveolin-2 on tyrosine 19. Phospho-caveolin-2 (Tyr(P)19) is localized near focal adhesions, remains associated with lipid rafts/caveolae, but no longer forms a high molecular mass hetero-oligomer with caveolin-1. The Journal of Biological Chemistry. 277: 34556-67. PMID 12091389 DOI: 10.1074/Jbc.M204367200 |
0.578 |
|
| 2002 |
Razani B, Park DS, Miyanaga Y, Ghatpande A, Cohen J, Wang XB, Scherer PE, Evans T, Lisanti MP. Molecular cloning and developmental expression of the caveolin gene family in the amphibian Xenopus laevis. Biochemistry. 41: 7914-24. PMID 12069580 DOI: 10.1021/Bi020043N |
0.613 |
|
| 2002 |
Park DS, Woodman SE, Schubert W, Cohen AW, Frank PG, Chandra M, Shirani J, Razani B, Tang B, Jelicks LA, Factor SM, Weiss LM, Tanowitz HB, Lisanti MP. Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. The American Journal of Pathology. 160: 2207-17. PMID 12057923 DOI: 10.1016/S0002-9440(10)61168-6 |
0.798 |
|
| 2002 |
Sotgia F, Razani B, Bonuccelli G, Schubert W, Battista M, Lee H, Capozza F, Schubert AL, Minetti C, Buckley JT, Lisanti MP. Intracellular retention of glycosylphosphatidyl inositol-linked proteins in caveolin-deficient cells. Molecular and Cellular Biology. 22: 3905-26. PMID 11997523 DOI: 10.1128/Mcb.22.11.3905-3926.2002 |
0.821 |
|
| 2002 |
Schubert AL, Schubert W, Spray DC, Lisanti MP. Connexin family members target to lipid raft domains and interact with caveolin-1. Biochemistry. 41: 5754-64. PMID 11980479 DOI: 10.1021/Bi0121656 |
0.715 |
|
| 2002 |
Woodman SE, Schlegel A, Cohen AW, Lisanti MP. Mutational analysis identifies a short atypical membrane attachment sequence (KYWFYR) within caveolin-1. Biochemistry. 41: 3790-5. PMID 11888297 DOI: 10.1021/Bi0120751 |
0.698 |
|
| 2002 |
Razani B, Wang XB, Engelman JA, Battista M, Lagaud G, Zhang XL, Kneitz B, Hou H, Christ GJ, Edelmann W, Lisanti MP. Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Molecular and Cellular Biology. 22: 2329-44. PMID 11884617 DOI: 10.1128/Mcb.22.7.2329-2344.2002 |
0.737 |
|
| 2002 |
Liu J, Wang XB, Park DS, Lisanti MP. Caveolin-1 expression enhances endothelial capillary tubule formation Journal of Biological Chemistry. 277: 10661-10668. PMID 11748236 DOI: 10.1074/Jbc.M110354200 |
0.404 |
|
| 2002 |
Razani B, Combs TP, Wang XB, Frank PG, Park DS, Russell RG, Li M, Tang B, Jelicks LA, Scherer PE, Lisanti MP. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. The Journal of Biological Chemistry. 277: 8635-47. PMID 11739396 DOI: 10.1074/Jbc.M110970200 |
0.748 |
|
| 2002 |
Schlegel A, Lisanti MP. Withdrawal of “The caveolin triad: caveolae biogenesis, cholesterol trafficking, and signal transduction” [Cytokine & Growth Factor Reviews 12(1) (2001) 41–51] Cytokine & Growth Factor Reviews. 13: 289. DOI: 10.1016/S1359-6101(02)00013-8 |
0.524 |
|
| 2001 |
Razani B, Lisanti MP. Caveolin-deficient mice: insights into caveolar function human disease. The Journal of Clinical Investigation. 108: 1553-61. PMID 11733547 DOI: 10.1172/Jci14611 |
0.658 |
|
| 2001 |
Sotgia F, Lee H, Bedford MT, Petrucci T, Sudol M, Lisanti MP. Tyrosine phosphorylation of beta-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins. Biochemistry. 40: 14585-92. PMID 11724572 DOI: 10.1021/Bi011247R |
0.526 |
|
| 2001 |
Razani B, Lisanti MP. Caveolins and caveolae: molecular and functional relationships. Experimental Cell Research. 271: 36-44. PMID 11697880 DOI: 10.1006/Excr.2001.5372 |
0.555 |
|
| 2001 |
Schubert W, Frank PG, Razani B, Park DS, Chow CW, Lisanti MP. Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo. The Journal of Biological Chemistry. 276: 48619-22. PMID 11689550 DOI: 10.1074/Jbc.C100613200 |
0.798 |
|
| 2001 |
Park DS, Lee H, Riedel C, Hulit J, Scherer PE, Pestell RG, Lisanti MP. Prolactin negatively regulates caveolin-1 gene expression in the mammary gland during lactation, via a Ras-dependent mechanism. The Journal of Biological Chemistry. 276: 48389-97. PMID 11602600 DOI: 10.1074/Jbc.M108210200 |
0.691 |
|
| 2001 |
Galbiati F, Razani B, Lisanti MP. Caveolae and caveolin-3 in muscular dystrophy. Trends in Molecular Medicine. 7: 435-41. PMID 11597517 DOI: 10.1016/S1471-4914(01)02105-0 |
0.629 |
|
| 2001 |
Schlegel A, Wang C, Pestell RG, Lisanti MP. Ligand-independent activation of oestrogen receptor alpha by caveolin-1. The Biochemical Journal. 359: 203-10. PMID 11563984 DOI: 10.1042/0264-6021:3590203 |
0.654 |
|
| 2001 |
Razani B, Lisanti MP. Two distinct caveolin-1 domains mediate the functional interaction of caveolin-1 with protein kinase A. American Journal of Physiology. Cell Physiology. 281: C1241-50. PMID 11546661 DOI: 10.1152/Ajpcell.2001.281.4.C1241 |
0.626 |
|
| 2001 |
Frank PG, Pedraza A, Cohen DE, Lisanti MP. Adenovirus-mediated expression of caveolin-1 in mouse liver increases plasma high-density lipoprotein levels Biochemistry. 40: 10892-10900. PMID 11535066 DOI: 10.1021/Bi0106437 |
0.647 |
|
| 2001 |
Galbiati F, Razani B, Lisanti MP. Emerging themes in lipid rafts and caveolae. Cell. 106: 403-11. PMID 11525727 DOI: 10.1016/S0092-8674(01)00472-X |
0.577 |
|
| 2001 |
Galbiati F, Volonte' D, Liu J, Capozza F, Frank PG, Zhu L, Pestell RG, Lisanti MP. Caveolin-1 expression negatively regulates cell cycle progression by inducing G0/G1 arrest via a p53/p21WAF1/Cip1-dependent mechanism Molecular Biology of the Cell. 12: 2229-2244. PMID 11514613 DOI: 10.1091/Mbc.12.8.2229 |
0.711 |
|
| 2001 |
Razani B, Schlegel A, Liu J, Lisanti MP. Caveolin-1, a putative tumour suppressor gene. Biochemical Society Transactions. 29: 494-9. PMID 11498016 DOI: 10.1042/Bst0290494 |
0.737 |
|
| 2001 |
Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H, Kneitz B, Lagaud G, Christ GJ, ... ... Lisanti MP, et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. The Journal of Biological Chemistry. 276: 38121-38. PMID 11457855 DOI: 10.1074/Jbc.M105408200 |
0.826 |
|
| 2001 |
Lee H, Woodman SE, Engelman JA, Volonté D, Galbiati F, Kaufman HL, Lublin DM, Lisanti MP. Palmitoylation of caveolin-1 at a single site (Cys-156) controls its coupling to the c-Src tyrosine kinase: targeting of dually acylated molecules (GPI-linked, transmembrane, or cytoplasmic) to caveolae effectively uncouples c-Src and caveolin-1 (TYR-14). The Journal of Biological Chemistry. 276: 35150-8. PMID 11451957 DOI: 10.1074/Jbc.M104530200 |
0.748 |
|
| 2001 |
Fine SW, Lisanti MP, Galbiati F, Li M. Elevated expression of caveolin-1 in adenocarcinoma of the colon American Journal of Clinical Pathology. 115: 719-724. PMID 11345836 DOI: 10.1309/Yl54-Ccu7-4V0P-Fdut |
0.343 |
|
| 2001 |
Schlegel A, Lisanti MP. The caveolin triad: caveolae biogenesis, cholesterol trafficking, and signal transduction. Cytokine & Growth Factor Reviews. 12: 41-51. PMID 11312118 DOI: 10.1016/S1359-6101(00)00022-8 |
0.586 |
|
| 2001 |
Wang C, Fu M, D'Amico M, Albanese C, Zhou JN, Brownlee M, Lisanti MP, Chatterjee VK, Lazar MA, Pestell RG. Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1. Molecular and Cellular Biology. 21: 3057-70. PMID 11287611 DOI: 10.1128/Mcb.21.9.3057-3070.2001 |
0.499 |
|
| 2001 |
Frank PG, Galbiati F, Volonte D, Razani B, Cohen DE, Marcel YL, Lisanti MP. Influence of caveolin-1 on cellular cholesterol efflux mediated by high-density lipoproteins. American Journal of Physiology. Cell Physiology. 280: C1204-14. PMID 11287334 DOI: 10.1152/Ajpcell.2001.280.5.C1204 |
0.789 |
|
| 2001 |
Wang C, Fu M, Angeletti RH, Siconolfi-Baez L, Reutens AT, Albanese C, Lisanti MP, Katzenellenbogen BS, Kato S, Hopp T, Fuqua SA, Lopez GN, Kushner PJ, Pestell RG. Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity. The Journal of Biological Chemistry. 276: 18375-83. PMID 11279135 DOI: 10.1074/Jbc.M100800200 |
0.485 |
|
| 2001 |
Galbiati F, Engelman JA, Volonte D, Zhang XL, Minetti C, Li M, Hou H, Kneitz B, Edelmann W, Lisanti MP. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. The Journal of Biological Chemistry. 276: 21425-33. PMID 11259414 DOI: 10.1074/Jbc.M100828200 |
0.599 |
|
| 2001 |
Park DS, Razani B, Lasorella A, Schreiber-Agus N, Pestell RG, Iavarone A, Lisanti MP. Evidence that Myc isoforms transcriptionally repress caveolin-1 gene expression via an INR-dependent mechanism. Biochemistry. 40: 3354-62. PMID 11258956 DOI: 10.1021/Bi002787B |
0.689 |
|
| 2001 |
Liu J, Lee P, Galbiati F, Kitsis RN, Lisanti MP. Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation. American Journal of Physiology. Cell Physiology. 280: C823-35. PMID 11245599 DOI: 10.1152/Ajpcell.2001.280.4.C823 |
0.337 |
|
| 2001 |
Schlegel A, Lisanti MP. Caveolae and their coat proteins, the caveolins: from electron microscopic novelty to biological launching pad. Journal of Cellular Physiology. 186: 329-37. PMID 11169971 DOI: 10.1002/1097-4652(2001)9999:9999<000::Aid-Jcp1045>3.0.Co;2-0 |
0.573 |
|
| 2001 |
Razani B, Zhang XL, Bitzer M, von Gersdorff G, Böttinger EP, Lisanti MP. Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor. The Journal of Biological Chemistry. 276: 6727-38. PMID 11102446 DOI: 10.1074/Jbc.M008340200 |
0.588 |
|
| 2001 |
Volonté D, Galbiati F, Pestell RG, Lisanti MP. Cellular stress induces the tyrosine phosphorylation of caveolin-1 (Tyr14) via activation of p38 mitogen-activated protein kinase and c-Src kinase. Evidence for caveolae, the actin cytoskeleton, and focal adhesions as mechanical sensors of osmotic stress Journal of Biological Chemistry. 276: 8094-8103. PMID 11094059 DOI: 10.1074/Jbc.M009245200 |
0.475 |
|
| 2001 |
Schlegel A, Arvan P, Lisanti MP. Caveolin-1 binding to endoplasmic reticulum membranes and entry into the regulated secretory pathway are regulated by serine phosphorylation. Protein sorting at the level of the endoplasmic reticulum. The Journal of Biological Chemistry. 276: 4398-408. PMID 11078729 DOI: 10.1074/Jbc.M005448200 |
0.619 |
|
| 2001 |
SCHLEGEL A, WANG C, PESTELL RG, LISANTI MP. Ligand-independent activation of oestrogen receptor α by caveolin-1 Biochemical Journal. 359: 203-210. DOI: 10.1042/bj3590203 |
0.428 |
|
| 2001 |
Bouzahzah B, Albanese C, Ahmed F, Pixley F, Lisanti MP, Segall JD, Condeelis J, Joyce D, Minden A, Der CJ, Chan A, Symons M, Pestell RG. Rho Family GTPases Regulate Mammary Epithelium Cell Growth and Metastasis Through Distinguishable Pathways Molecular Medicine. 7: 816-830. DOI: 10.1007/Bf03401974 |
0.603 |
|
| 2000 |
Zafonte BT, Hulit J, Amanatullah DF, Albanese C, Wang C, Rosen E, Reutens A, Sparano JA, Lisanti MP, Pestell RG. Cell-cycle dysregulation in breast cancer: breast cancer therapies targeting the cell cycle Frontiers in Bioscience : a Journal and Virtual Library. 5. PMID 11102317 DOI: 10.2741/Zafonte |
0.532 |
|
| 2000 |
Schlegel A, Pestell RG, Lisanti MP. Caveolins in cholesterol trafficking and signal transduction: implications for human disease. Frontiers in Bioscience : a Journal and Virtual Library. 5: D929-37. PMID 11102315 |
0.632 |
|
| 2000 |
Huang H, Petkova SB, Pestell RG, Bouzahzah B, Chan J, Magazine H, Weiss LM, Christ GJ, Lisanti MP, Douglas SA, Shtutin V, Halonen SK, Wittner M, Tanowitz HB. Trypanosoma cruzi infection (Chagas' disease) of mice causes activation of the mitogen-activated protein kinase cascade and expression of endothelin-1 in the myocardium. Journal of Cardiovascular Pharmacology. 36: S148-50. PMID 11078362 DOI: 10.1097/00005344-200036051-00046 |
0.517 |
|
| 2000 |
Razani B, Altschuler Y, Zhu L, Pestell RG, Mostov KE, Lisanti MP. Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation. Biochemistry. 39: 13916-24. PMID 11076533 DOI: 10.1021/Bi001489B |
0.689 |
|
| 2000 |
Lee H, Volonte D, Galbiati F, Iyengar P, Lublin DM, Bregman DB, Wilson MT, Campos-Gonzalez R, Bouzahzah B, Pestell RG, Scherer PE, Lisanti MP. Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Molecular Endocrinology (Baltimore, Md.). 14: 1750-75. PMID 11075810 DOI: 10.1210/Mend.14.11.0553 |
0.632 |
|
| 2000 |
Engelman JA, Berg AH, Lewis RY, Lisanti MP, Scherer PE. Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes. Molecular Endocrinology (Baltimore, Md.). 14: 1557-69. PMID 11043572 DOI: 10.1210/Mend.14.10.0542 |
0.539 |
|
| 2000 |
Rybin VO, Xu X, Lisanti MP, Steinberg SF. Differential targeting of β-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae: A mechanism to functionally regulate the cAMP signaling pathway Journal of Biological Chemistry. 275: 41447-41457. PMID 11006286 DOI: 10.1074/Jbc.M006951200 |
0.314 |
|
| 2000 |
Galbiati F, Volonte D, Chu JB, Li M, Fine SW, Fu M, Bermudez J, Pedemonte M, Weidenheim KM, Pestell RG, Minetti C, Lisanti MP. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. Proceedings of the National Academy of Sciences of the United States of America. 97: 9689-94. PMID 10931944 DOI: 10.1073/Pnas.160249097 |
0.518 |
|
| 2000 |
D'Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B, Fu M, Augenlicht LH, Donehower LA, Takemaru KI, Moon RT, Davis R, Lisanti MP, Shtutman M, Zhurinsky J, et al. The integrated-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3β and cAMP-responsive element-binding protein-dependent pathways Journal of Biological Chemistry. 275: 32649-32657. PMID 10915780 DOI: 10.1074/Jbc.M000643200 |
0.524 |
|
| 2000 |
Razani B, Schlegel A, Lisanti MP. Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy. Journal of Cell Science. 113: 2103-9. PMID 10825283 |
0.696 |
|
| 2000 |
Lin Y, Lee H, Berg AH, Lisanti MP, Shapiro L, Scherer PE. The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. The Journal of Biological Chemistry. 275: 24255-63. PMID 10823826 DOI: 10.1074/Jbc.M002137200 |
0.534 |
|
| 2000 |
Galbiati F, Volonte D, Brown AM, Weinstein DE, Ben-Ze'ev A, Pestell RG, Lisanti MP. Caveolin-1 expression inhibits Wnt/beta-catenin/Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains. The Journal of Biological Chemistry. 275: 23368-77. PMID 10816572 DOI: 10.1074/Jbc.M002020200 |
0.494 |
|
| 2000 |
Schlegel A, Lisanti MP. A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo. The Journal of Biological Chemistry. 275: 21605-17. PMID 10801850 DOI: 10.1074/Jbc.M002558200 |
0.57 |
|
| 2000 |
Park H, Go YM, Darji R, Choi JW, Lisanti MP, Maland MC, Jo H. Caveolin-1 regulates shear stress-dependent activation of extracellular signal-regulated kinase. American Journal of Physiology. Heart and Circulatory Physiology. 278: H1285-93. PMID 10749726 DOI: 10.1152/Ajpheart.2000.278.4.H1285 |
0.35 |
|
| 2000 |
Zhang W, Razani B, Altschuler Y, Bouzahzah B, Mostov KE, Pestell RG, Lisanti MP. Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). Transformation suppressor effects of adenovirus-mediated gene delivery of caveolin-1. The Journal of Biological Chemistry. 275: 20717-25. PMID 10748172 DOI: 10.1074/Jbc.M909895199 |
0.703 |
|
| 2000 |
Hulit J, Bash T, Fu M, Galbiati F, Albanese C, Sage DR, Schlegel A, Zhurinsky J, Shtutman M, Ben-Ze'ev A, Lisanti MP, Pestell RG. The cyclin D1 gene is transcriptionally repressed by caveolin-1. The Journal of Biological Chemistry. 275: 21203-9. PMID 10747899 DOI: 10.1074/Jbc.M000321200 |
0.657 |
|
| 1999 |
Engelman JA, Berg AH, Lewis RY, Lin A, Lisanti MP, Scherer PE. Constitutively active mitogen-activated protein kinase kinase 6 (MKK6) or salicylate induces spontaneous 3T3-L1 adipogenesis. The Journal of Biological Chemistry. 274: 35630-8. PMID 10585441 DOI: 10.1074/Jbc.274.50.35630 |
0.567 |
|
| 1999 |
Schlegel A, Wang C, Katzenellenbogen BS, Pestell RG, Lisanti MP. Caveolin-1 potentiates estrogen receptor alpha (ERalpha) signaling. caveolin-1 drives ligand-independent nuclear translocation and activation of ERalpha. The Journal of Biological Chemistry. 274: 33551-6. PMID 10559241 DOI: 10.1074/Jbc.274.47.33551 |
0.656 |
|
| 1999 |
Engelman JA, Zhang XL, Razani B, Pestell RG, Lisanti MP. p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression. Activation of Ras-MAP kinase and protein kinase a signaling cascades transcriptionally down-regulates caveolin-1 promoter activity. The Journal of Biological Chemistry. 274: 32333-41. PMID 10542274 DOI: 10.1074/Jbc.274.45.32333 |
0.744 |
|
| 1999 |
Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, Lisanti MP. Caveolins, liquid-ordered domains, and signal transduction. Molecular and Cellular Biology. 19: 7289-304. PMID 10523618 DOI: 10.1128/Mcb.19.11.7289 |
0.577 |
|
| 1999 |
Galbiati F, Volonte D, Engelman JA, Scherer PE, Lisanti MP. Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. The Journal of Biological Chemistry. 274: 30315-21. PMID 10514527 DOI: 10.1074/Jbc.274.42.30315 |
0.607 |
|
| 1999 |
Bà thori G, Parolini I, Tombola F, Szabò I, Messina A, Oliva M, De Pinto V, Lisanti M, Sargiacomo M, Zoratti M. Porin is present in the plasma membrane where it is concentrated in caveolae and caveolae-related domains. The Journal of Biological Chemistry. 274: 29607-12. PMID 10514428 DOI: 10.1074/Jbc.274.42.29607 |
0.303 |
|
| 1999 |
Razani B, Rubin CS, Lisanti MP. Regulation of cAMP-mediated signal transduction via interaction of caveolins with the catalytic subunit of protein kinase A. The Journal of Biological Chemistry. 274: 26353-60. PMID 10473592 DOI: 10.1074/Jbc.274.37.26353 |
0.645 |
|
| 1999 |
Parolini I, Sargiacomo M, Galbiati F, Rizzo G, Grignani F, Engelman JA, Okamoto T, Ikezu T, Scherer PE, Mora R, Rodriguez-Boulan E, Peschle C, Lisanti MP. Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the golgi complex. The Journal of Biological Chemistry. 274: 25718-25. PMID 10464309 DOI: 10.1074/Jbc.274.36.25718 |
0.673 |
|
| 1999 |
Mora R, Bonilha VL, Marmorstein A, Scherer PE, Brown D, Lisanti MP, Rodriguez-Boulan E. Caveolin-2 localizes to the golgi complex but redistributes to plasma membrane, caveolae, and rafts when co-expressed with caveolin-1. The Journal of Biological Chemistry. 274: 25708-17. PMID 10464308 DOI: 10.1074/Jbc.274.36.25708 |
0.598 |
|
| 1999 |
Galbiati F, Volonte D, Minetti C, Chu JB, Lisanti MP. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex. The Journal of Biological Chemistry. 274: 25632-41. PMID 10464299 DOI: 10.1074/Jbc.274.36.25632 |
0.34 |
|
| 1999 |
Schwab W, Galbiati F, Volonte D, Hempel U, Wenzel KW, Funk RH, Lisanti MP, Kasper M. Characterisation of caveolins from cartilage: expression of caveolin-1, -2 and -3 in chondrocytes and in alginate cell culture of the rat tibia. Histochemistry and Cell Biology. 112: 41-9. PMID 10461811 DOI: 10.1007/S004180050390 |
0.315 |
|
| 1999 |
Repetto S, Bado M, Broda P, Lucania G, Masetti E, Sotgia F, Carbone I, Pavan A, Bonilla E, Cordone G, Lisanti MP, Minetti C. Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy. Biochemical and Biophysical Research Communications. 261: 547-50. PMID 10441463 DOI: 10.1006/Bbrc.1999.1055 |
0.326 |
|
| 1999 |
Schlegel A, Schwab RB, Scherer PE, Lisanti MP. A role for the caveolin scaffolding domain in mediating the membrane attachment of caveolin-1. The caveolin scaffolding domain is both necessary and sufficient for membrane binding in vitro. The Journal of Biological Chemistry. 274: 22660-7. PMID 10428847 DOI: 10.1074/Jbc.274.32.22660 |
0.575 |
|
| 1999 |
Lisanti MP, Sargiacomo M, Scherer PE. Purification of caveolae-derived membrane microdomains containing lipid-anchored signaling molecules, such as GPI-anchored proteins, H-Ras, Src-family tyrosine kinases, eNOS, and G-protein alpha-, beta-, and gamma-subunits Methods in Molecular Biology (Clifton, N.J.). 116: 51-60. PMID 10399145 DOI: 10.1385/1-59259-264-3:51 |
0.301 |
|
| 1999 |
Das K, Lewis RY, Scherer PE, Lisanti MP. The membrane-spanning domains of caveolins-1 and -2 mediate the formation of caveolin hetero-oligomers. Implications for tile assembly of caveolae membranes in vivo Journal of Biological Chemistry. 274: 18721-18728. PMID 10373486 DOI: 10.1074/Jbc.274.26.18721 |
0.384 |
|
| 1999 |
Liu J, Razani B, Tang S, Terman BI, Ware JA, Lisanti MP. Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1. The Journal of Biological Chemistry. 274: 15781-5. PMID 10336480 DOI: 10.1074/Jbc.274.22.15781 |
0.622 |
|
| 1999 |
Parolini I, Topa S, Sorice M, Pace A, Ceddia P, Montesoro E, Pavan A, Lisanti MP, Peschle C, Sargiacomo M. Phorbol ester-induced disruption of the CD4-Lck complex occurs within a detergent-resistant microdomain of the plasma membrane. Involvement of the translocation of activated protein kinase C isoforms. The Journal of Biological Chemistry. 274: 14176-87. PMID 10318836 DOI: 10.1074/Jbc.274.20.14176 |
0.344 |
|
| 1999 |
Engelman JA, Zhang XL, Lisanti MP. Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 5' promoter region of the caveolin-1 gene in human breast cancer cell lines. Febs Letters. 448: 221-30. PMID 10218480 DOI: 10.1016/S0014-5793(99)00365-8 |
0.562 |
|
| 1999 |
Volonte D, Galbiati F, Li S, Nishiyama K, Okamoto T, Lisanti MP. Flotillins/cavatellins are differentially expressed in cells and tissues and form a hetero-oligomeric complex with caveolins in vivo. Characterization and epitope-mapping of a novel flotillin-1 monoclonal antibody probe. The Journal of Biological Chemistry. 274: 12702-9. PMID 10212252 DOI: 10.1074/Jbc.274.18.12702 |
0.656 |
|
| 1999 |
Volontè D, Galbiati F, Lisanti MP. Visualization of caveolin-1, a caveolar marker protein, in living cells using green fluorescent protein (GFP) chimeras. The subcellular distribution of caveolin-1 is modulated by cell-cell contact Febs Letters. 445: 431-439. PMID 10094502 DOI: 10.1016/S0014-5793(99)00164-7 |
0.392 |
|
| 1999 |
Carman CV, Lisanti MP, Benovic JL. Regulation of G protein-coupled receptor kinases by caveolin Journal of Biological Chemistry. 274: 8858-8864. PMID 10085129 DOI: 10.1074/Jbc.274.13.8858 |
0.331 |
|
| 1999 |
Bilderback TR, Gazula VR, Lisanti MP, Dobrowsky RT. Caveolin interacts with Trk A and p75(NTR) and regulates neurotrophin signaling pathways Journal of Biological Chemistry. 274: 257-263. PMID 9867838 DOI: 10.1074/Jbc.274.1.257 |
0.357 |
|
| 1998 |
Li S, Lisanti M, Puszkin S. Purification and molecular characterization of NP185, a neuronal-specific and synapse-enriched clathrin assembly polypeptide. Bioquimica Y Patologia Clinica : Bypc : Revista De La Asociacion Bioquimica Argentina. 62: 5-17. PMID 31402847 |
0.69 |
|
| 1998 |
Yang CPH, Galbiati F, Volonté D, Horwitz SB, Lisanti MP. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells Febs Letters. 439: 368-372. PMID 9845355 DOI: 10.1016/S0014-5793(98)01354-4 |
0.303 |
|
| 1998 |
Ikezu T, Ueda H, Trapp BD, Nishiyama K, Sha JF, Volonte D, Galbiati F, Byrd AL, Bassell G, Serizawa H, Lane WS, Lisanti MP, Okamoto T. Affinity-purification and characterization of caveolins from the brain: differential expression of caveolin-1, -2, and -3 in brain endothelial and astroglial cell types. Brain Research. 804: 177-92. PMID 9841091 DOI: 10.1016/S0006-8993(98)00498-3 |
0.349 |
|
| 1998 |
Engelman JA, Zhang X, Galbiati F, Volonte D, Sotgia F, Pestell RG, Minetti C, Scherer PE, Okamoto T, Lisanti MP. Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy. American Journal of Human Genetics. 63: 1578-87. PMID 9837809 DOI: 10.1086/302172 |
0.601 |
|
| 1998 |
Park H, Go YM, St John PL, Maland MC, Lisanti MP, Abrahamson DR, Jo H. Plasma membrane cholesterol is a key molecule in shear stress-dependent activation of extracellular signal-regulated kinase. The Journal of Biological Chemistry. 273: 32304-11. PMID 9822710 DOI: 10.1074/Jbc.273.48.32304 |
0.33 |
|
| 1998 |
Engelman JA, Lisanti MP, Scherer PE. Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. The Journal of Biological Chemistry. 273: 32111-20. PMID 9822687 DOI: 10.1074/Jbc.273.48.32111 |
0.546 |
|
| 1998 |
Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG, Lisanti MP. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. The Embo Journal. 17: 6633-48. PMID 9822607 DOI: 10.1093/Emboj/17.22.6633 |
0.693 |
|
| 1998 |
Engelman JA, Zhang XL, Lisanti MP. Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers. Febs Letters. 436: 403-10. PMID 9801158 DOI: 10.1016/S0014-5793(98)01134-X |
0.539 |
|
| 1998 |
Schlegel A, Volonte D, Engelman JA, Galbiati F, Mehta P, Zhang XL, Scherer PE, Lisanti MP. Crowded little caves: structure and function of caveolae. Cellular Signalling. 10: 457-63. PMID 9754713 DOI: 10.1016/S0898-6568(98)00007-2 |
0.695 |
|
| 1998 |
Li S, Galbiati F, Volonte D, Sargiacomo M, Engelman JA, Das K, Scherer PE, Lisanti MP. Mutational analysis of caveolin-induced vesicle formation. Expression of caveolin-1 recruits caveolin-2 to caveolae membranes. Febs Letters. 434: 127-34. PMID 9738464 DOI: 10.1016/S0014-5793(98)00945-4 |
0.713 |
|
| 1998 |
Galbiati F, Volonte D, Gil O, Zanazzi G, Salzer JL, Sargiacomo M, Scherer PE, Engelman JA, Schlegel A, Parenti M, Okamoto T, Lisanti MP. Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury. Proceedings of the National Academy of Sciences of the United States of America. 95: 10257-62. PMID 9707634 DOI: 10.1073/Pnas.95.17.10257 |
0.706 |
|
| 1998 |
Engelman JA, Lee RJ, Karnezis A, Bearss DJ, Webster M, Siegel P, Muller WJ, Windle JJ, Pestell RG, Lisanti MP. Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer. The Journal of Biological Chemistry. 273: 20448-55. PMID 9685399 DOI: 10.1074/Jbc.273.32.20448 |
0.692 |
|
| 1998 |
Engelman JA, Zhang XL, Galbiati F, Lisanti MP. Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3). Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/7q31). Febs Letters. 429: 330-6. PMID 9662443 DOI: 10.1016/S0014-5793(98)00619-X |
0.56 |
|
| 1998 |
Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS, Lisanti MP. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. Febs Letters. 428: 205-11. PMID 9654135 DOI: 10.1016/S0014-5793(98)00470-0 |
0.565 |
|
| 1998 |
Galbiati F, Volonte D, Goltz JS, Steele Z, Sen J, Jurcsak J, Stein D, Stevens L, Lisanti MP. Identification, sequence and developmental expression of invertebrate flotillins from Drosophila melanogaster. Gene. 210: 229-37. PMID 9573373 DOI: 10.1016/S0378-1119(98)00064-X |
0.349 |
|
| 1998 |
Ikezu T, Trapp BD, Song KS, Schlegel A, Lisanti MP, Okamoto T. Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein. The Journal of Biological Chemistry. 273: 10485-95. PMID 9553108 DOI: 10.1074/Jbc.273.17.10485 |
0.569 |
|
| 1998 |
Minetti C, Sotgia F, Bruno C, Scartezzini P, Broda P, Bado M, Masetti E, Mazzocco M, Egeo A, Donati MA, Volonte D, Galbiati F, Cordone G, Bricarelli FD, Lisanti MP, et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nature Genetics. 18: 365-8. PMID 9537420 DOI: 10.1038/Ng0498-365 |
0.31 |
|
| 1998 |
McNally EM, de Sá Moreira E, Duggan DJ, Bönnemann CG, Lisanti MP, Lidov HG, Vainzof M, Passos-Bueno MR, Hoffman EP, Zatz M, Kunkel LM. Caveolin-3 in muscular dystrophy. Human Molecular Genetics. 7: 871-7. PMID 9536092 DOI: 10.1093/Hmg/7.5.871 |
0.367 |
|
| 1998 |
Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. The Journal of Biological Chemistry. 273: 5419-22. PMID 9488658 DOI: 10.1074/Jbc.273.10.5419 |
0.56 |
|
| 1998 |
Breton S, Lisanti MP, Tyszkowski R, McLaughlin M, Brown D. Basolateral distribution of caveolin-1 in the kidney: Absence from H+- ATPase-coated endocytic vesicles in intercalated cells Journal of Histochemistry and Cytochemistry. 46: 205-214. PMID 9446827 DOI: 10.1177/002215549804600209 |
0.352 |
|
| 1997 |
Couet J, Sargiacomo M, Lisanti MP. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities Journal of Biological Chemistry. 272: 30429-30438. PMID 9374534 DOI: 10.1074/Jbc.272.48.30429 |
0.315 |
|
| 1997 |
Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet J, Kohtz DS, van Donselaar E, Peters P, Lisanti MP. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. The Journal of Biological Chemistry. 272: 29337-46. PMID 9361015 DOI: 10.1074/Jbc.272.46.29337 |
0.622 |
|
| 1997 |
García-Cardeña G, Martasek P, Masters BS, Skidd PM, Couet J, Li S, Lisanti MP, Sessa WC. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. The Journal of Biological Chemistry. 272: 25437-40. PMID 9325253 DOI: 10.1074/Jbc.272.41.25437 |
0.349 |
|
| 1997 |
Scherer PE, Lisanti MP. Association of phosphofructokinase-M with caveolin-3 in differentiated skeletal myotubes: Dynamic regulation by extracellular glucose and intracellular metabolites Journal of Biological Chemistry. 272: 20698-20705. PMID 9252390 DOI: 10.1074/Jbc.272.33.20698 |
0.324 |
|
| 1997 |
Kübler E, Mösch HU, Rupp S, Lisanti MP. Gpa2p, a G-protein α-subunit, regulates growth and pseudohyphal development in Saccharomyces cerevisiae via a cAMP-dependent mechanism Journal of Biological Chemistry. 272: 20321-20323. PMID 9252333 DOI: 10.1074/Jbc.272.33.20321 |
0.332 |
|
| 1997 |
Engelman JA, Wykoff CC, Yasuhara S, Song KS, Okamoto T, Lisanti MP. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. The Journal of Biological Chemistry. 272: 16374-81. PMID 9195944 DOI: 10.1074/Jbc.272.26.16374 |
0.608 |
|
| 1997 |
Bickel PE, Scherer PE, Schnitzer JE, Oh P, Lisanti MP, Lodish HF. Flotillin and epidermal surface antigen define a new family of caveolae- associated integral membrane proteins Journal of Biological Chemistry. 272: 13793-13802. PMID 9153235 DOI: 10.1074/Jbc.272.21.13793 |
0.312 |
|
| 1997 |
Song KS, Tang Z, Li S, Lisanti MP. Mutational analysis of the properties of caveolin-1. A novel role for the C-terminal domain in mediating homo-typic caveolin-caveolin interactions Journal of Biological Chemistry. 272: 4398-4403. PMID 9020162 DOI: 10.1074/Jbc.272.7.4398 |
0.599 |
|
| 1997 |
Tang Z, Okamoto T, Boontrakulpoontawee P, Katada T, Otsuka AJ, Lisanti MP. Identification, sequence, and expression of an invertebrate caveolin gene family from the nematode Caenorhabditis elegans. Implications for the molecular evolution of mammalian caveolin genes. The Journal of Biological Chemistry. 272: 2437-45. PMID 8999956 DOI: 10.1074/Jbc.272.4.2437 |
0.34 |
|
| 1997 |
Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP. Identification of peptide and protein ligands for the caveolin- scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins Journal of Biological Chemistry. 272: 6525-6533. DOI: 10.1074/Jbc.272.10.6525 |
0.592 |
|
| 1997 |
Couet J, Shengwen L, Okamoto T, Scherer PE, Lisanti MP. Molecular and cellular biology of caveolae: Paradoxes and plasticities Trends in Cardiovascular Medicine. 7: 103-110. DOI: 10.1016/S1050-1738(97)00001-7 |
0.395 |
|
| 1996 |
Kübler E, Dohlman HG, Lisanti MP. Identification of Triton X-100 insoluble membrane domains in the yeast Saccharomyces cerevisiae: Lipid requirements for targeting of heterotrimeric G-protein subunits Journal of Biological Chemistry. 271: 32975-32980. PMID 8955141 DOI: 10.1074/Jbc.271.51.32975 |
0.314 |
|
| 1996 |
Li S, Couet J, Lisanti MP. Src tyrosine kinases, G(α) subunits, and H-Ras share a common membrane- anchored scaffolding protein, caveolin: Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases Journal of Biological Chemistry. 271: 29182-29190. PMID 8910575 DOI: 10.1074/Jbc.271.46.29182 |
0.622 |
|
| 1996 |
Li S, Song KS, Koh SS, Kikuchi A, Lisanti MP. Baculovirus-based expression of mammalian caveolin in Sf21 insect cells: A model system for the biochemical and morphological study of caveolae biogenesis Journal of Biological Chemistry. 271: 28647-28654. PMID 8910498 DOI: 10.1074/Jbc.271.45.28647 |
0.65 |
|
| 1996 |
Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, Lisanti MP. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. The Journal of Biological Chemistry. 271: 15160-5. PMID 8663016 DOI: 10.1074/Jbc.271.25.15160 |
0.629 |
|
| 1996 |
Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains: Detergent-free purification of caveolae membranes Journal of Biological Chemistry. 271: 9690-9697. PMID 8621645 DOI: 10.1074/Jbc.271.16.9690 |
0.603 |
|
| 1996 |
Parolini I, Sargiacomo M, Lisanti MP, Peschle C. Signal transduction and glycophosphatidylinositol-linked proteins (LYN, LCK, CD4, CD45, G proteins, and CD55) selectively localize in triton-insoluble plasma membrane domains of human leukemic cell lines and normal granulocytes Blood. 87: 3783-3794. PMID 8611704 DOI: 10.1182/Blood.V87.9.3783.Bloodjournal8793783 |
0.333 |
|
| 1996 |
Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, Lisanti MP. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. The Journal of Biological Chemistry. 271: 2255-61. PMID 8567687 DOI: 10.1074/Jbc.271.4.2255 |
0.358 |
|
| 1996 |
Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF, Lisanti MP. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family Proceedings of the National Academy of Sciences of the United States of America. 93: 131-135. PMID 8552590 DOI: 10.1073/Pnas.93.1.131 |
0.356 |
|
| 1996 |
Li S, Song KS, Lisanti MP. Expression and characterization of recombinant caveolin: Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes Journal of Biological Chemistry. 271: 568-573. PMID 8550621 DOI: 10.1074/Jbc.271.1.568 |
0.625 |
|
| 1996 |
Li S, Seitz R, Lisanti MP. Phosphorylation of Caveolin by Src Tyrosine Kinases Journal of Biological Chemistry. 271: 3863-3868. DOI: 10.1074/Jbc.271.7.3863 |
0.606 |
|
| 1995 |
Koleske AJ, Baltimore D, Lisanti MP. Reduction of caveolin and caveolae in oncogenically transformed cells. Proceedings of the National Academy of Sciences of the United States of America. 92: 1381-5. PMID 7877987 DOI: 10.1073/Pnas.92.5.1381 |
0.349 |
|
| 1995 |
Kuliawat R, Lisanti MP, Arvan P. Polarized distribution and delivery of plasma membrane proteins in thyroid follicular epithelial cells Journal of Biological Chemistry. 270: 2478-2482. PMID 7852309 DOI: 10.1074/Jbc.270.6.2478 |
0.302 |
|
| 1995 |
Lisanti MP, Tang Z, Scherer PE, Kübler E, Koleske AJ, Sargiacomo M. Caveolae, transmembrane signalling and cellular transformation. Molecular Membrane Biology. 12: 121-4. PMID 7767370 DOI: 10.3109/09687689509038506 |
0.371 |
|
| 1995 |
Lisanti MP, Tang Z, Scherer PE, Sargiacomo M. Caveolae purification and glycosylphosphatidylinositol-linked protein sorting in polarized epithelia Methods in Enzymology. 250: 655-668. PMID 7651184 DOI: 10.1016/0076-6879(95)50103-7 |
0.329 |
|
| 1995 |
Scherer PE, Tang Z, Chun M, Sargiacomo M, Lodish HF, Lisanti MP. Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution: Identification and epitope mapping of an isoform-specific monoclonal antibody probe Journal of Biological Chemistry. 270: 16395-16401. PMID 7608210 DOI: 10.1074/Jbc.270.27.16395 |
0.31 |
|
| 1995 |
Sargiacomo M, Scherer PE, Tang Z, Kübler E, Song KS, Sanders MC, Lisanti MP. Oligomeric structure of caveolin: Implications for caveolae membrane organization Proceedings of the National Academy of Sciences of the United States of America. 92: 9407-9411. PMID 7568142 DOI: 10.1073/Pnas.92.20.9407 |
0.313 |
|
| 1995 |
Lisanti MP, Scherer PE, Tang Z, Kübler E, Koleske AJ, Sargiacomo M. Caveolae and human disease: functional roles in transcytosis, potocytosis, signalling and cell polarity Seminars in Developmental Biology. 6: 47-58. DOI: 10.1016/S1044-5781(06)80084-8 |
0.393 |
|
| 1994 |
Scherer PE, Lisanti MP, Baldini G, Sargiacomo M, Mastick CC, Lodish HF. Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles Journal of Cell Biology. 127: 1233-1243. PMID 7962086 DOI: 10.1083/Jcb.127.5.1233 |
0.319 |
|
| 1994 |
Tang Z, Scherer PE, Lisanti MP. The primary sequence of murine caveolin reveals a conserved consensus site for phosphorylation by protein kinase C Gene. 147: 299-300. PMID 7926819 DOI: 10.1016/0378-1119(94)90087-6 |
0.325 |
|
| 1994 |
Lisanti MP, Scherer PE, Vidugiriene J, Tang Z, Hermanowski-Vosatka A, Tu YH, Cook RF, Sargiacomo M. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. The Journal of Cell Biology. 126: 111-26. PMID 7517942 DOI: 10.1083/Jcb.126.1.111 |
0.377 |
|
| 1994 |
Lisanti MP, Scherer PE, Tang Z, Sargiacomo M. Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis Trends in Cell Biology. 4: 231-235. DOI: 10.1016/0962-8924(94)90114-7 |
0.332 |
|
| 1993 |
Hannan LA, Lisanti MP, Rodriguez-Boulan E, Edidin M. Correctly sorted molecules of a GPI-anchored protein are clustered and immobile when they arrive at the apical surface of MDCK cells Journal of Cell Biology. 120: 353-358. PMID 8380601 DOI: 10.1083/Jcb.120.2.353 |
0.5 |
|
| 1993 |
Sargiacomo M, Sudol M, Tang Z, Lisanti MP. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells Journal of Cell Biology. 122: 789-807. PMID 8349730 DOI: 10.1083/Jcb.122.4.789 |
0.37 |
|
| Show low-probability matches. |
